_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,orig_e1,orig_e2,expertdecision,relation,sent_id,orig_sentence,term1,term2
502805246,7/13/2014 11:30:00,,1321838201,7/13/2014 11:29:55,neodev,1,17610000,GBR,I2,Manchester,90.200.140.201,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"knwon exposure to TUBERCULOSIS, two positive responses USDA",41-47-56-59-73-77-86-99,86-96-99-104-115-120-133-77,positive responses to USDA TUBERCULIN were demonstrated and,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805246,7/13/2014 11:40:15,,1321842157,7/13/2014 11:40:01,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"TUBERCULOSIS,",59,99-104,USDA TUBERCULIN,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805246,7/13/2014 11:43:24,,1321843559,7/13/2014 11:43:10,gifthulk,1,22552178,AUS,05,Adelaide,121.45.89.85,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"TUBERCULOSIS,",59,104,TUBERCULIN,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805246,7/13/2014 11:44:35,,1321843985,7/13/2014 11:44:27,clixsense,1,24763049,GBR,"","",86.133.47.213,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"knwon exposure to TUBERCULOSIS, two positive responses",41-47-56-59-73-77-86,86-96-99-104-115-120-133,responses to USDA TUBERCULIN were demonstrated and,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805246,7/13/2014 11:52:38,,1321846995,7/13/2014 11:52:36,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"knwon exposure to TUBERCULOSIS, two positive responses",41-47-56-59-73-77-86,86-96-99-104-115-120-133,responses to USDA TUBERCULIN were demonstrated and,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805246,7/13/2014 11:53:14,,1321847217,7/13/2014 11:52:59,tremorgames,1,26860817,NLD,06,Boxmeer,84.29.157.221,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"TUBERCULOSIS,",59,104,TUBERCULIN,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805246,7/13/2014 11:59:04,,1321849442,7/13/2014 11:58:34,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"TUBERCULOSIS,",59,99-104,USDA TUBERCULIN,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805246,7/13/2014 11:59:33,,1321849649,7/13/2014 11:59:22,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"TUBERCULOSIS,",59,99-104,USDA TUBERCULIN,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805246,7/13/2014 12:00:55,,1321850234,7/13/2014 12:00:35,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"exposure to TUBERCULOSIS,",47-56-59,104,TUBERCULIN,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805246,7/13/2014 12:02:50,,1321850930,7/13/2014 12:02:38,neodev,1,18755947,GBR,H2,Accrington,80.47.185.52,59,104,,,71,114,TUBERCULOSIS,TUBERCULIN,"TUBERCULOSIS,",59,99-104,USDA TUBERCULIN,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD.",59,104,59,104,71,114,1,RO-may_diagnose,906772,"In a comparison group of 70 dogs without knwon exposure to tuberculosis, two positive responses to USDA tuberculin were demonstrated and none to PPD",tuberculosis,tuberculin
502805247,7/13/2014 11:37:28,,1321841100,7/13/2014 11:37:12,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,bone marrow (THROMBOCYTHEMIA.,175-180-187,115,(THROMBOCYTOSIS),Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805247,7/13/2014 11:39:01,,1321841704,7/13/2014 11:38:37,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,(THROMBOCYTHEMIA.,187,115,(THROMBOCYTOSIS),Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805247,7/13/2014 11:39:12,,1321841790,7/13/2014 11:38:41,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,primary disorder bone marrow (THROMBOCYTHEMIA.,159-175-180-187-151,95-104-115,systemic conditions (THROMBOCYTOSIS),Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805247,7/13/2014 11:41:31,,1321842732,7/13/2014 11:41:23,clixsense,1.0,24763049,GBR,"","",86.133.47.213,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,bone marrow (THROMBOCYTHEMIA.,175-180-187,95-104-115-132-135-139,systemic conditions (THROMBOCYTOSIS) or may represent,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805247,7/13/2014 11:57:27,,1321848792,7/13/2014 11:56:48,vivatic,1.0,25451531,GBR,"","",83.67.28.193,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,(THROMBOCYTHEMIA.,187,115,(THROMBOCYTOSIS),Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805247,7/13/2014 12:01:37,,1321850491,7/13/2014 12:00:43,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,bone marrow (THROMBOCYTHEMIA.,175-180-187,115,(THROMBOCYTOSIS),Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805247,7/13/2014 12:01:46,,1321850516,7/13/2014 12:01:34,neodev,1.0,18755947,GBR,H2,Accrington,80.47.185.52,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,(THROMBOCYTHEMIA.,187,115,(THROMBOCYTOSIS),Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805247,7/13/2014 12:03:52,,1321851244,7/13/2014 12:03:36,instagc,1.0,13763729,USA,"","",75.182.89.225,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,(THROMBOCYTHEMIA.,187,115,(THROMBOCYTOSIS),Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805247,7/13/2014 12:05:03,,1321851629,7/13/2014 12:04:51,neodev,1.0,18517457,GBR,"","",86.29.147.112,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,(THROMBOCYTHEMIA.,187,115,(THROMBOCYTOSIS),Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805247,7/13/2014 12:06:14,,1321852077,7/13/2014 12:05:47,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,188,116,,,203,130,THROMBOCYTHEMIA,THROMBOCYTOSIS,(THROMBOCYTHEMIA.,187,115,(THROMBOCYTOSIS),Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia.,,,188,116,203,130,-1,RO-has_definitional_manifestation,904548,Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia,thrombocythemia,thrombocytosis
502805248,7/13/2014 11:31:12,,1321838678,7/13/2014 11:31:05,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,which the risk of NEURAL TUBE DEFECTS.,136-140-145-148-155-160-122,96-99-104-110-116-122-128-136-86,"even it does (e.g. FOLIC ACID, which reduces the","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805248,7/13/2014 11:38:51,,1321841652,7/13/2014 11:38:37,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,NEURAL TUBE DEFECTS.,148-155-160,110-116,"FOLIC ACID,","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805248,7/13/2014 11:41:00,,1321842526,7/13/2014 11:40:37,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,NEURAL TUBE DEFECTS.,148-155-160,110-116-148-155-160,"FOLIC ACID, neural tube defects.","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805248,7/13/2014 11:42:43,,1321843341,7/13/2014 11:42:30,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,NEURAL TUBE DEFECTS.,148-155-160,110-116,"FOLIC ACID,","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805248,7/13/2014 11:43:58,,1321843781,7/13/2014 11:43:43,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,NEURAL TUBE DEFECTS.,148-155-160,110-116,"FOLIC ACID,","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805248,7/13/2014 11:45:07,,1321844230,7/13/2014 11:44:43,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,risk of NEURAL TUBE DEFECTS.,140-148-155-160-145,110-116,"FOLIC ACID,","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805248,7/13/2014 11:45:20,,1321844331,7/13/2014 11:45:13,clixsense,1.0,24763049,GBR,"","",86.133.47.213,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,the risk of NEURAL TUBE DEFECTS.,136-140-145-148-155-160,96-99-104-110-116-122-128-136,"it does (e.g. FOLIC ACID, which reduces the","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805248,7/13/2014 11:55:45,,1321848144,7/13/2014 11:55:27,vivatic,1.0,25451531,GBR,"","",83.67.28.193,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,NEURAL TUBE DEFECTS.,148-155-160,110-116,"FOLIC ACID,","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805248,7/13/2014 12:06:13,,1321852074,7/13/2014 12:05:31,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,NEURAL TUBE DEFECTS.,148-155-160,110-116,"FOLIC ACID,","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805248,7/13/2014 12:06:48,,1321852229,7/13/2014 12:06:34,neodev,1.0,18517457,GBR,"","",86.29.147.112,148,110,,,167,120,NEURAL TUBE DEFECTS,FOLIC ACID,NEURAL TUBE DEFECTS.,148-155-160,110-116,"FOLIC ACID,","At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects.",148 155 160,110 116,148,110,167,120,1,RO-may_prevent,907227,"At the same time, regulations may forbid claims that a food product prevents disease, even when it does (e.g. folic acid, which reduces the risk of neural tube defects",neural tube defects,folic acid
502805249,7/13/2014 11:29:48,,1321838089,7/13/2014 11:29:41,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,199,151,,,211,159,HYPERTENSION,LOSARTAN,Endpoint reduction in HYPERTENSION study a atenolol.,177-186-196-199-212-226-253,135-144-147-151-160-173-177-253,diabetes in the LOSARTAN Intervention For Endpoint atenolol.,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805249,7/13/2014 11:34:25,,1321840034,7/13/2014 11:33:44,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,199,151,,,211,159,HYPERTENSION,LOSARTAN,HYPERTENSION (LIFE):,199-218,151-160,LOSARTAN Intervention,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805249,7/13/2014 11:34:41,,1321840179,7/13/2014 11:34:17,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,199,151,,,211,159,HYPERTENSION,LOSARTAN,HYPERTENSION,199,151,LOSARTAN,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805249,7/13/2014 11:42:15,,1321843103,7/13/2014 11:41:55,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,199,151,,,211,159,HYPERTENSION,LOSARTAN,HYPERTENSION,199,151,LOSARTAN,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805249,7/13/2014 11:52:05,,1321846769,7/13/2014 11:51:43,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,199,151,,,211,159,HYPERTENSION,LOSARTAN,HYPERTENSION,199,135-151,diabetes LOSARTAN,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805249,7/13/2014 11:54:52,,1321847804,7/13/2014 11:54:37,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,199,151,,,211,159,HYPERTENSION,LOSARTAN,Endpoint reduction in HYPERTENSION,177-186-196-199,151-160,LOSARTAN Intervention,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805249,7/13/2014 11:55:43,,1321848136,7/13/2014 11:55:00,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,199,151,,,211,159,HYPERTENSION,LOSARTAN,HYPERTENSION,199,151,LOSARTAN,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805249,7/13/2014 11:59:36,,1321849709,7/13/2014 11:59:03,vivatic,1.0,25451531,GBR,"","",83.67.28.193,199,151,,,211,159,HYPERTENSION,LOSARTAN,HYPERTENSION,199,151-160,LOSARTAN Intervention,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805249,7/13/2014 12:01:46,,1321850515,7/13/2014 12:01:11,instagc,1.0,13763729,USA,"","",75.182.89.225,199,151,,,211,159,HYPERTENSION,LOSARTAN,HYPERTENSION,199,151-160-173-177-186-196-199-212,LOSARTAN Intervention For Endpoint reduction in hypertension study,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805249,7/13/2014 12:02:37,,1321850846,7/13/2014 12:01:46,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,199,151,,,211,159,HYPERTENSION,LOSARTAN,HYPERTENSION,199,151-160-173-177,LOSARTAN Intervention For Endpoint,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.",199,151,199,151,211,159,1,RO-may_treat,907486,"1]  Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",hypertension,Losartan
502805250,7/13/2014 11:34:59,,1321840243,7/13/2014 11:34:43,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,ALLERGY,94,124,HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805250,7/13/2014 11:48:32,,1321845461,7/13/2014 11:48:20,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,ALLERGY,94,124,HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805250,7/13/2014 12:04:14,,1321851364,7/13/2014 12:03:52,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,ALLERGY,94,109-119-124,immediate type HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805250,7/13/2014 12:07:04,,1321852328,7/13/2014 12:06:50,instagc,1.0,13763729,USA,"","",75.182.89.225,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,ALLERGY,94,124,HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805250,7/13/2014 12:07:12,,1321852393,7/13/2014 12:06:57,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,ALLERGY,94,124,HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805250,7/13/2014 12:07:58,,1321852649,7/13/2014 12:07:45,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,ALLERGY,94,124,HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805250,7/13/2014 12:09:34,,1321853221,7/13/2014 12:09:15,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,the development of ALLERGY,75-79-91-94,79-91-94-105-109-119-124-102,development of allergy of the immediate type HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805250,7/13/2014 12:14:19,,1321854758,7/13/2014 12:13:55,gifthulk,1.0,25566511,USA,"","",24.164.11.173,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,ALLERGY,94,124,HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805250,7/13/2014 12:14:27,,1321854780,7/13/2014 12:14:11,instagc,1,19378092,USA,PA,Reading,174.55.181.238,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,ALLERGY,94,124,HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805250,7/13/2014 12:14:46,,1321854881,7/13/2014 12:14:34,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,94,124,,,101,140,ALLERGY,HYPERSENSITIVITY,ALLERGY,94,124,HYPERSENSITIVITY.,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity.,94,124,94,124,101,140,-1,RO-cause_of,900083,These data support the hypothesis concerning a pathogenetic role of IFN in the development of allergy of the immediate type hypersensitivity,allergy,hypersensitivity
502805251,7/13/2014 11:44:26,,1321843957,7/13/2014 11:44:18,clixsense,1.0,24763049,GBR,"","",86.133.47.213,262,231,,,268,246,GLUTEN,COELIAC DISEASE,treated with a GLUTEN free diet for,247-255-260-262-269-274-279,213-217-226-231-239-247-255-260,the patients with COELIAC DISEASE treated with a,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805251,7/13/2014 11:44:42,,1321844005,7/13/2014 11:44:22,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,262,231,,,268,246,GLUTEN,COELIAC DISEASE,GLUTEN free diet,262-269-274,217-226-231-239,patients with COELIAC DISEASE,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805251,7/13/2014 11:50:48,,1321846249,7/13/2014 11:50:22,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,262,231,,,268,246,GLUTEN,COELIAC DISEASE,GLUTEN,262,231-239,COELIAC DISEASE,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805251,7/13/2014 11:52:31,,1321846954,7/13/2014 11:52:28,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,262,231,,,268,246,GLUTEN,COELIAC DISEASE,treated with a GLUTEN free diet for,247-255-260-262-269-274-279,213-217-226-231-239-247-255-260,the patients with COELIAC DISEASE treated with a,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805251,7/13/2014 11:55:07,,1321847878,7/13/2014 11:54:53,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,262,231,,,268,246,GLUTEN,COELIAC DISEASE,GLUTEN free diet,262-269-274,231-239,COELIAC DISEASE,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805251,7/13/2014 12:00:48,,1321850158,7/13/2014 12:00:20,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,262,231,,,268,246,GLUTEN,COELIAC DISEASE,GLUTEN free,262-269,231-239,COELIAC DISEASE,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805251,7/13/2014 12:01:09,,1321850299,7/13/2014 11:59:18,instagc,1.0,13763729,USA,"","",75.182.89.225,262,231,,,268,246,GLUTEN,COELIAC DISEASE,GLUTEN free diet,262-269-274,231-239,COELIAC DISEASE,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805251,7/13/2014 12:05:16,,1321851707,7/13/2014 12:04:53,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,262,231,,,268,246,GLUTEN,COELIAC DISEASE,GLUTEN free,262-269,231-239,COELIAC DISEASE,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805251,7/13/2014 12:09:14,,1321853058,7/13/2014 12:08:44,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,262,231,,,268,246,GLUTEN,COELIAC DISEASE,GLUTEN free diet,262-269-274,231-239-247-255-260-262-268-269-274,COELIAC DISEASE treated with a gluten - free diet,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805251,7/13/2014 12:09:48,,1321853305,7/13/2014 12:09:22,gifthulk,1.0,25566511,USA,"","",24.164.11.173,262,231,,,268,246,GLUTEN,COELIAC DISEASE,GLUTEN free diet,262-269-274,231-239,COELIAC DISEASE,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01.,262,231 239,262,231,268,246,-1,RO-has_causative_agent,903747,The 5-HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten-free diet for less than a year (p less than 0.01) but also compared with the patients with coeliac disease treated with a gluten-free diet for more than a year (p less than 0.01,gluten,coeliac disease
502805252,7/13/2014 11:36:00,,1321840597,7/13/2014 11:35:48,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,131,61,,,135,74,PAIN,ACETAMINOPHEN,migraine headache PAIN.,113-122-131,61-76-85-89,"ACETAMINOPHEN, aspirin, and caffeine","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805252,7/13/2014 11:41:22,,1321842659,7/13/2014 11:41:14,clixsense,1.0,24763049,GBR,"","",86.133.47.213,131,61,,,135,74,PAIN,ACETAMINOPHEN,alleviating migraine headache PAIN.,101-113-122-131,47-51-58-61-76-85-89,"and safety of ACETAMINOPHEN, aspirin, and caffeine","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805252,7/13/2014 11:52:04,,1321846768,7/13/2014 11:52:00,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,131,61,,,135,74,PAIN,ACETAMINOPHEN,alleviating migraine headache PAIN.,101-113-122-131,47-51-58-61-76-85-89,"and safety of ACETAMINOPHEN, aspirin, and caffeine","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805252,7/13/2014 11:56:01,,1321848285,7/13/2014 11:55:41,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,131,61,,,135,74,PAIN,ACETAMINOPHEN,migraine headache PAIN.,113-122-131,61-113-122,"ACETAMINOPHEN, migraine headache","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805252,7/13/2014 12:05:06,,1321851642,7/13/2014 12:04:48,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,131,61,,,135,74,PAIN,ACETAMINOPHEN,alleviating migraine headache PAIN.,101-113-122-131,61,"ACETAMINOPHEN,","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805252,7/13/2014 12:05:29,,1321851772,7/13/2014 12:04:51,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,131,61,,,135,74,PAIN,ACETAMINOPHEN,PAIN.,131,61,"ACETAMINOPHEN,","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805252,7/13/2014 12:09:27,,1321853208,7/13/2014 12:09:11,instagc,1.0,13763729,USA,"","",75.182.89.225,131,61,,,135,74,PAIN,ACETAMINOPHEN,migraine headache PAIN.,113-122-131,61,"ACETAMINOPHEN,","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805252,7/13/2014 12:11:08,,1321853689,7/13/2014 12:10:46,gifthulk,1.0,25566511,USA,"","",24.164.11.173,131,61,,,135,74,PAIN,ACETAMINOPHEN,migraine headache PAIN.,113-122-131,61-76-85-89,"ACETAMINOPHEN, aspirin, and caffeine","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805252,7/13/2014 12:11:17,,1321853745,7/13/2014 12:11:04,neodev,1.0,18517457,GBR,"","",86.29.147.112,131,61,,,135,74,PAIN,ACETAMINOPHEN,migraine headache PAIN.,113-122-131,61,"ACETAMINOPHEN,","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805252,7/13/2014 12:13:46,,1321854542,7/13/2014 12:13:23,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,131,61,,,135,74,PAIN,ACETAMINOPHEN,alleviating migraine headache PAIN.,101-113-122-131,61-76-85-89,"ACETAMINOPHEN, aspirin, and caffeine","Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain.",131,61,131,61,135,74,1,RO-may_treat,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain",pain,acetaminophen
502805253,7/13/2014 11:27:42,,1321837319,7/13/2014 11:27:36,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,"of trivalent inactivated POLIOVIRUS vaccine (IPV), consisting",69-72-82-94-105-120-113,16-20-24-36-52-54-62-113,"for all children POLIOMYELITIS: A primary series (IPV),","It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805253,7/13/2014 11:35:47,,1321840524,7/13/2014 11:35:24,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,"trivalent inactivated POLIOVIRUS vaccine (IPV),",72-82-94-105-113,36-52-54-62-69-72-82-94-105-113,"POLIOMYELITIS: A primary series of trivalent inactivated poliovirus vaccine (IPV),","It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805253,7/13/2014 11:41:27,,1321842673,7/13/2014 11:41:08,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,POLIOVIRUS,94,36,POLIOMYELITIS:,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805253,7/13/2014 11:43:01,,1321843400,7/13/2014 11:42:52,clixsense,1.0,24763049,GBR,"","",86.133.47.213,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,of trivalent inactivated POLIOVIRUS vaccine consisting,69-72-82-94-105-120,16-20-24-36-52-54-62,for all children POLIOMYELITIS: A primary series,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805253,7/13/2014 11:46:33,,1321844779,7/13/2014 11:46:05,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,"POLIOVIRUS vaccine (IPV),",94-105-113,36-72-82-94-105-113,"POLIOMYELITIS: trivalent inactivated poliovirus vaccine (IPV),","It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805253,7/13/2014 11:52:35,,1321846982,7/13/2014 11:52:32,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,of trivalent inactivated POLIOVIRUS vaccine consisting,69-72-82-94-105-120,16-20-24-36-52-54-62,for all children POLIOMYELITIS: A primary series,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805253,7/13/2014 11:54:52,,1321847803,7/13/2014 11:54:33,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,POLIOVIRUS,94,36,POLIOMYELITIS:,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805253,7/13/2014 11:57:18,,1321848750,7/13/2014 11:57:07,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,trivalent inactivated POLIOVIRUS vaccine,72-82-94-105,36,POLIOMYELITIS:,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805253,7/13/2014 11:57:50,,1321848952,7/13/2014 11:57:00,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,"of trivalent inactivated POLIOVIRUS vaccine (IPV),",69-72-82-94-105-113,36,POLIOMYELITIS:,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805253,7/13/2014 11:58:20,,1321849160,7/13/2014 11:57:54,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,94,36,,,104,49,POLIOVIRUS,POLIOMYELITIS,inactivated POLIOVIRUS vaccine,82-94-105,24-36,children POLIOMYELITIS:,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",94,36,94,36,104,49,-1,RO-has_causative_agent,903549,"It is indicated for all children    Poliomyelitis:  A primary series of trivalent inactivated poliovirus vaccine (IPV), consisting of a mixture of formalin-inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients",poliovirus,Poliomyelitis
502805254,7/13/2014 11:31:50,,1321838900,7/13/2014 11:31:40,clixsense,1.0,24763049,GBR,"","",86.133.47.213,76,44,,,84,55,VOMITING,ANTIEMETICS,in preventing early VOMITING 0.89,56-59-70-76-91,28-33-41-44-56-59-70,were similar to ANTIEMETICS in preventing early,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805254,7/13/2014 11:32:37,,1321839208,7/13/2014 11:32:16,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,76,44,,,84,55,VOMITING,ANTIEMETICS,VOMITING,76,44,ANTIEMETICS,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805254,7/13/2014 11:46:34,,1321844789,7/13/2014 11:46:13,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,76,44,,,84,55,VOMITING,ANTIEMETICS,preventing early VOMITING,59-70-76,44,ANTIEMETICS,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805254,7/13/2014 11:52:23,,1321846927,7/13/2014 11:52:21,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,76,44,,,84,55,VOMITING,ANTIEMETICS,in preventing early VOMITING 0.89,56-59-70-76-91,28-33-41-44-56-59-70,were similar to ANTIEMETICS in preventing early,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805254,7/13/2014 11:54:19,,1321847618,7/13/2014 11:53:55,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,76,44,,,84,55,VOMITING,ANTIEMETICS,VOMITING,76,44,ANTIEMETICS,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805254,7/13/2014 11:57:38,,1321848857,7/13/2014 11:57:03,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,76,44,,,84,55,VOMITING,ANTIEMETICS,VOMITING,76,44,ANTIEMETICS,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805254,7/13/2014 12:04:08,,1321851307,7/13/2014 12:03:53,instagc,1.0,13763729,USA,"","",75.182.89.225,76,44,,,84,55,VOMITING,ANTIEMETICS,VOMITING,76,44,ANTIEMETICS,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805254,7/13/2014 12:04:08,,1321851313,7/13/2014 12:03:55,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,76,44,,,84,55,VOMITING,ANTIEMETICS,VOMITING,76,44,ANTIEMETICS,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805254,7/13/2014 12:04:49,,1321851545,7/13/2014 12:04:30,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,76,44,,,84,55,VOMITING,ANTIEMETICS,early VOMITING,70-76,44,ANTIEMETICS,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805254,7/13/2014 12:10:58,,1321853664,7/13/2014 12:10:24,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,76,44,,,84,55,VOMITING,ANTIEMETICS,VOMITING,76,44,ANTIEMETICS,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults.,76,44,76,44,84,55,1,RO-may_prevent,907029,Nonpharmacologic techniques were similar to antiemetics in preventing early vomiting (RR = 0.89 [95% confidence interval 0.47-1.67]; NNT = 63 [10-infinity]) and late vomiting (RR = 0.80 [0.35-1.81]; NNT = 25 [5-infinity]) in adults,vomiting,antiemetics
502805255,7/13/2014 11:30:55,,1321838596,7/13/2014 11:30:45,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,43,117,,,53,129,FREEMARTIN,VIRILIZATION,of anti M����渇�膩�����鐃緒申鐃順�riaN ACTIVITY in Freemartin with,13-16-21-45-54-57-75,101-104-107-118-123-131-93,tubules is an indication THAT GONADAl virilization,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805255,7/13/2014 11:38:36,,1321841571,7/13/2014 11:38:09,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,43,117,,,53,129,FREEMARTIN,VIRILIZATION,Freemartin,57,131,virilization,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805255,7/13/2014 11:40:00,,1321842070,7/13/2014 11:39:36,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,43,117,,,53,129,FREEMARTIN,VIRILIZATION,ACTIVITY Freemartin gonads,45-57-68,123-131,GONADAl virilization,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805255,7/13/2014 11:43:33,,1321843643,7/13/2014 11:43:12,clixsense,1.0,24763049,GBR,"","",86.133.47.213,43,117,,,53,129,FREEMARTIN,VIRILIZATION,of anti M����渇�膩�����鐃緒申鐃順�riaN ACTIVITY in Freemartin,13-16-21-45-54-57,101-104-107-118-123-131,is an indication THAT GONADAl virilization,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805255,7/13/2014 11:53:26,,1321847253,7/13/2014 11:53:13,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,43,117,,,53,129,FREEMARTIN,VIRILIZATION,anti M����渇�膩�����鐃緒申鐃順�riaN ACTIVITY,16-21-45,101-123-131,is GONADAl virilization,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805255,7/13/2014 11:56:40,,1321848558,7/13/2014 11:55:44,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,43,117,,,53,129,FREEMARTIN,VIRILIZATION,Freemartin gonads,57-68,123,GONADAl,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805255,7/13/2014 12:04:07,,1321851294,7/13/2014 12:03:48,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,43,117,,,53,129,FREEMARTIN,VIRILIZATION,Freemartin,57,123-131,GONADAl virilization,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805255,7/13/2014 12:05:26,,1321851755,7/13/2014 12:05:05,instagc,1.0,13763729,USA,"","",75.182.89.225,43,117,,,53,129,FREEMARTIN,VIRILIZATION,Freemartin,57,123-131,GONADAl virilization,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805255,7/13/2014 12:07:12,,1321852397,7/13/2014 12:06:48,neodev,1.0,18517457,GBR,"","",86.29.147.112,43,117,,,53,129,FREEMARTIN,VIRILIZATION,Freemartin,57,123-131,GONADAl virilization,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805255,7/13/2014 12:10:21,,1321853475,7/13/2014 12:09:34,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,43,117,,,53,129,FREEMARTIN,VIRILIZATION,ACTIVITY in Freemartin gonads with seminiferous tubules,45-54-57-68-75-80-93,45-54-57-68-75-80-101-104-107-118-123-131-93,activity in Freemartin gonads with seminiferous tubules is an indication THAT GONADAl virilization,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological.,,,43,117,53,129,-1,RO-cause_of,900426,The presence of anti-M����渇�膩�����鐃緒申鐃順�rian activity in Freemartin gonads with seminiferous tubules is an indication that gonadal virilization in these fetuses is functional as well as morphological,Freemartin,virilization
502805256,7/13/2014 11:28:40,,1321837620,7/13/2014 11:28:34,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,celiac disease as STEATORRHEA and diarrhea is not,40-47-55-58-70-74-83-86,20-28-37-40-47-55-58-70-86,classic features of CELIAC DISEASE as steatorrhea and not,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805256,7/13/2014 11:38:08,,1321841323,7/13/2014 11:37:34,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,STEATORRHEA,58,40-47,CELIAC DISEASE,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805256,7/13/2014 11:44:06,,1321843827,7/13/2014 11:43:57,clixsense,1.0,24763049,GBR,"","",86.133.47.213,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,celiac disease as STEATORRHEA and diarrhea is,40-47-55-58-70-74-83,20-28-37-40-47-55-58-70,classic features of CELIAC DISEASE as steatorrhea and,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805256,7/13/2014 11:52:00,,1321846727,7/13/2014 11:51:56,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,celiac disease as STEATORRHEA and diarrhea is,40-47-55-58-70-74-83,20-28-37-40-47-55-58-70,classic features of CELIAC DISEASE as steatorrhea and,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805256,7/13/2014 11:59:08,,1321849474,7/13/2014 11:58:56,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,STEATORRHEA,58,40-47,CELIAC DISEASE,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805256,7/13/2014 12:03:01,,1321850967,7/13/2014 12:02:41,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,STEATORRHEA,58,40-47,CELIAC DISEASE,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805256,7/13/2014 12:03:07,,1321850997,7/13/2014 12:02:51,neodev,1.0,18755947,GBR,H2,Accrington,80.47.185.52,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,STEATORRHEA,58,40-47,CELIAC DISEASE,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805256,7/13/2014 12:04:59,,1321851622,7/13/2014 12:04:35,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,STEATORRHEA,58,40-47,CELIAC DISEASE,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805256,7/13/2014 12:07:36,,1321852538,7/13/2014 12:07:20,instagc,1.0,13763729,USA,"","",75.182.89.225,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,STEATORRHEA,58,40-47,CELIAC DISEASE,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805256,7/13/2014 12:09:42,,1321853266,7/13/2014 12:08:45,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,58,40,,,69,54,STEATORRHEA,CELIAC DISEASE,STEATORRHEA,58,40-47,CELIAC DISEASE,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation.,58,40 47,58,40,69,54,1,RO-has_manifestation,906282,The absence of such classic features of celiac disease as steatorrhea and diarrhea is not an uncommon presentation,steatorrhea,celiac disease
502805257,7/13/2014 11:36:22,,1321840718,7/13/2014 11:35:29,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,"ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA), allergic Aspergillus sinusitis (AAS)",124-133-150-164-172-181-193-203,25-36-48-65-77-37,Aspergillus - associated HYPERSENSITIVITY respiratory disorders,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805257,7/13/2014 11:44:17,,1321843877,7/13/2014 11:44:07,clixsense,1.0,24763049,GBR,"","",86.133.47.213,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,"Aspergillus induced asthma, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS allergic Aspergillus",96-108-116-124-133-150-172-181,22-25-37-48-65-77-87,of Aspergillus associated HYPERSENSITIVITY respiratory disorders includes,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805257,7/13/2014 11:45:52,,1321844555,7/13/2014 11:45:35,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,124-133-150,48,HYPERSENSITIVITY,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805257,7/13/2014 11:51:38,,1321846564,7/13/2014 11:51:34,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,"Aspergillus induced asthma, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS allergic Aspergillus",96-108-116-124-133-150-172-181,22-25-37-48-65-77-87,of Aspergillus associated HYPERSENSITIVITY respiratory disorders includes,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805257,7/13/2014 11:52:27,,1321846917,7/13/2014 11:51:57,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,124-133-150,25-37-48-65-77,Aspergillus associated HYPERSENSITIVITY respiratory disorders,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805257,7/13/2014 11:53:54,,1321847446,7/13/2014 11:53:27,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,"Aspergillus asthma, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS allergic Aspergillus sinusitis hypersensitivity pneumonitis.",96-116-124-133-150-172-181-193-213-230,25-48-65-77-116-133-124,"Aspergillus HYPERSENSITIVITY respiratory disorders asthma, allergic bronchopulmonary","The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805257,7/13/2014 11:56:40,,1321848553,7/13/2014 11:56:25,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,"Aspergillus induced asthma, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA), allergic Aspergillus sinusitis (AAS)",96-108-116-124-133-150-164-172-181-193-203,25-37-48-65-77,Aspergillus associated HYPERSENSITIVITY respiratory disorders,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805257,7/13/2014 11:58:42,,1321849299,7/13/2014 11:58:24,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,124-133-150,25-37-48,Aspergillus associated HYPERSENSITIVITY,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805257,7/13/2014 12:00:48,,1321850157,7/13/2014 12:00:06,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,"ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA),",124-133-150-164,22-25-37-48-65-77,of Aspergillus associated HYPERSENSITIVITY respiratory disorders,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805257,7/13/2014 12:03:42,,1321851203,7/13/2014 12:03:21,neodev,1.0,18517457,GBR,"","",86.29.147.112,124,48,,,163,64,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,HYPERSENSITIVITY,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,124-133-150,22-48,of HYPERSENSITIVITY,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis.",124 133 150,48,124,48,163,64,1,RO-cause_of,900342,"The clinical spectrum of Aspergillus-associated hypersensitivity respiratory disorders includes Aspergillus induced asthma, allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis (AAS) and hypersensitivity pneumonitis",allergic bronchopulmonary aspergillosis,hypersensitivity
502805258,7/13/2014 11:27:01,,1321837076,7/13/2014 11:26:55,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,of NSAID associated DUODENAL ULCERS but misoprostol is more,81-84-90-101-110-117-121-133-136,13-16-28-32-43-47-50-136,H2 antagonists and SUCRALFATE are of similar more,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805258,7/13/2014 11:33:41,,1321839701,7/13/2014 11:33:21,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,NSAID associated DUODENAL ULCERS,84-90-101-110,32,SUCRALFATE,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805258,7/13/2014 11:41:32,,1321842740,7/13/2014 11:41:09,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,NSAID associated DUODENAL ULCERS,84-90-101-110,13-16-28-32,H2 antagonists and SUCRALFATE,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805258,7/13/2014 11:49:58,,1321845954,7/13/2014 11:49:02,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,DUODENAL ULCERS,101-110,32,SUCRALFATE,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805258,7/13/2014 11:52:54,,1321847099,7/13/2014 11:52:51,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,of NSAID associated DUODENAL ULCERS but misoprostol is,81-84-90-101-110-117-121-133,13-16-28-32-43-47-50,H2 antagonists and SUCRALFATE are of similar,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805258,7/13/2014 11:59:51,,1321849796,7/13/2014 11:59:34,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,DUODENAL ULCERS,101-110,32,SUCRALFATE,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805258,7/13/2014 12:03:29,,1321851160,7/13/2014 12:03:02,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,NSAID associated DUODENAL ULCERS,84-90-101-110,32,SUCRALFATE,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805258,7/13/2014 12:04:06,,1321851286,7/13/2014 12:03:27,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,NSAID - associated DUODENAL ULCERS,84-90-101-110-89,32,SUCRALFATE,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805258,7/13/2014 12:04:34,,1321851450,7/13/2014 12:04:10,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,NSAID associated DUODENAL ULCERS but misoprostol,84-90-101-110-117-121,13-16-28-32,H2 antagonists and SUCRALFATE,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805258,7/13/2014 12:08:29,,1321852790,7/13/2014 12:08:11,instagc,1.0,13763729,USA,"","",75.182.89.225,101,32,,,116,42,DUODENAL ULCERS,SUCRALFATE,DUODENAL ULCERS,101-110,32,SUCRALFATE,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers.",101 110,32,101,32,116,42,1,RO-may_prevent,907062,"Misoprostol, H2 antagonists and sucralfate are of similar efficacy in prevention of NSAID-associated duodenal ulcers but misoprostol is more effective in prevention of gastric ulcers",duodenal ulcers,sucralfate
502805259,7/13/2014 11:40:25,,1321842271,7/13/2014 11:40:06,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"seasonal and PERENNIAL ALLERGIC CONJUNCTIVITIS,",87-96-100-110-119,52-59-67,"ocular ALLERGY conditions,","The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805259,7/13/2014 11:43:28,,1321843600,7/13/2014 11:42:33,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"PERENNIAL ALLERGIC CONJUNCTIVITIS,",100-110-119,52-59,ocular ALLERGY,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805259,7/13/2014 11:49:53,,1321845920,7/13/2014 11:49:27,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"seasonal PERENNIAL ALLERGIC CONJUNCTIVITIS,",100-110-119-87,52-59-67,"ocular ALLERGY conditions,","The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805259,7/13/2014 11:49:54,,1321845925,7/13/2014 11:49:32,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"PERENNIAL ALLERGIC CONJUNCTIVITIS,",100-110-119,59,ALLERGY,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805259,7/13/2014 11:55:20,,1321847968,7/13/2014 11:54:54,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"PERENNIAL ALLERGIC CONJUNCTIVITIS,",100-110-119,59-67,"ALLERGY conditions,","The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805259,7/13/2014 11:59:53,,1321849827,7/13/2014 11:59:23,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"PERENNIAL ALLERGIC CONJUNCTIVITIS,",100-110-119,52-59,ocular ALLERGY,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805259,7/13/2014 12:06:14,,1321852083,7/13/2014 12:05:48,instagc,1.0,13763729,USA,"","",75.182.89.225,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"PERENNIAL ALLERGIC CONJUNCTIVITIS,",100-110-119,59-67-52,"ocular ALLERGY conditions,","The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805259,7/13/2014 12:09:21,,1321853148,7/13/2014 12:08:03,gifthulk,1.0,25566511,USA,"","",24.164.11.173,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"seasonal PERENNIAL ALLERGIC CONJUNCTIVITIS,",100-110-119-87,52-59,ocular ALLERGY,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805259,7/13/2014 12:10:12,,1321853449,7/13/2014 12:10:00,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"PERENNIAL ALLERGIC CONJUNCTIVITIS,",100-110-119,59,ALLERGY,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805259,7/13/2014 12:11:03,,1321853684,7/13/2014 12:10:46,neodev,1.0,18517457,GBR,"","",86.29.147.112,100,59,,,133,66,PERENNIAL ALLERGIC CONJUNCTIVITIS,ALLERGY,"PERENNIAL ALLERGIC CONJUNCTIVITIS,",100-110-119,45-52-59-67,"common ocular ALLERGY conditions,","The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone.",100 110 119,59,100,59,133,66,1,RO-cause_of,900088,"The ocular symptoms associated with the most common ocular allergy conditions, such as seasonal and perennial allergic conjunctivitis, are twice as likely to affect the allergy sufferer rather than nasal symptoms alone",perennial allergic conjunctivitis,allergy
502805260,7/13/2014 11:30:21,,1321838364,7/13/2014 11:30:15,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,377,331,,,384,345,THYROID,HYPOTHYROIDISM,with overt primary THYROID failure: cross sectional carcinoma,358-363-369-377-385-394-400-580,312-321-324-331-346-349-358-267,thyroid severity of tissue HYPOTHYROIDISM in patients with,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805260,7/13/2014 11:37:11,,1321841022,7/13/2014 11:36:56,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,377,331,,,384,345,THYROID,HYPOTHYROIDISM,with overt primary THYROID failure:,358-363-369-377-385,312-321-324-331,severity of tissue HYPOTHYROIDISM,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805260,7/13/2014 11:41:42,,1321842784,7/13/2014 11:41:33,clixsense,1.0,24763049,GBR,"","",86.133.47.213,377,331,,,384,345,THYROID,HYPOTHYROIDISM,with overt primary THYROID failure: cross sectional,358-363-369-377-385-394-400,312-321-324-331-346-349-358,severity of tissue HYPOTHYROIDISM in patients with,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805260,7/13/2014 11:42:35,,1321843254,7/13/2014 11:42:16,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,377,331,,,384,345,THYROID,HYPOTHYROIDISM,THYROID,377,331,HYPOTHYROIDISM,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805260,7/13/2014 11:45:07,,1321844217,7/13/2014 11:44:34,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,377,331,,,384,345,THYROID,HYPOTHYROIDISM,THYROID failure:,377-385,331-346-349-358-363-369-377-385,HYPOTHYROIDISM in patients with overt primary thyroid failure:,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805260,7/13/2014 11:50:38,,1321846165,7/13/2014 11:49:54,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,377,331,,,384,345,THYROID,HYPOTHYROIDISM,overt primary THYROID failure:,363-369-377-385,324-331,tissue HYPOTHYROIDISM,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805260,7/13/2014 11:51:18,,1321846424,7/13/2014 11:51:15,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,377,331,,,384,345,THYROID,HYPOTHYROIDISM,with overt primary THYROID failure: cross sectional,358-363-369-377-385-394-400,312-321-324-331-346-349-358,severity of tissue HYPOTHYROIDISM in patients with,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805260,7/13/2014 11:52:07,,1321846785,7/13/2014 11:51:49,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,377,331,,,384,345,THYROID,HYPOTHYROIDISM,overt primary THYROID failure:,363-369-377-385,324-331,tissue HYPOTHYROIDISM,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805260,7/13/2014 11:53:09,,1321847181,7/13/2014 11:52:38,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,377,331,,,384,345,THYROID,HYPOTHYROIDISM,THYROID Hypothyroidism:,377-455,331,HYPOTHYROIDISM,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805260,7/13/2014 12:01:58,,1321850616,7/13/2014 12:01:34,neodev,1.0,18517457,GBR,"","",86.29.147.112,377,331,,,384,345,THYROID,HYPOTHYROIDISM,THYROID,377,331,HYPOTHYROIDISM,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in.,377,331,377,331,384,345,1,RO-disease_has_primary_anatomic_site,902253,progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score  Subclinical hypothyroidism and functional mobility in older adults  British Medical Journal  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey  Disorders of sodium balance  Cancer  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma  Journal of the American Medical Association  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in,thyroid,hypothyroidism
502805261,7/13/2014 11:26:39,,1321836936,7/13/2014 11:26:29,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,106,150,,,117,154,DEHYDRATION,SALT,hydration the lack of DEHYDRATION with increasing temperature,94-98-103-106-118-123-134-60,123-134-146-150-155-73,the increasing temperature and SALT addition.,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805261,7/13/2014 11:39:15,,1321841804,7/13/2014 11:38:52,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,106,150,,,117,154,DEHYDRATION,SALT,DEHYDRATION with increasing temperature,106-118-123-134,123-134-146-150-155,increasing temperature and SALT addition.,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805261,7/13/2014 11:45:50,,1321844539,7/13/2014 11:45:08,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,106,150,,,117,154,DEHYDRATION,SALT,lack of DEHYDRATION,98-103-106,123-134-146-150-155,increasing temperature and SALT addition.,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805261,7/13/2014 11:50:21,,1321846051,7/13/2014 11:49:04,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,106,150,,,117,154,DEHYDRATION,SALT,DEHYDRATION temperature,106-134,134-150,temperature SALT,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805261,7/13/2014 11:53:50,,1321847418,7/13/2014 11:53:26,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,106,150,,,117,154,DEHYDRATION,SALT,DEHYDRATION,106,150,SALT,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805261,7/13/2014 11:57:49,,1321848950,7/13/2014 11:57:38,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,106,150,,,117,154,DEHYDRATION,SALT,DEHYDRATION,106,150,SALT,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805261,7/13/2014 12:00:32,,1321850059,7/13/2014 12:00:21,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,106,150,,,117,154,DEHYDRATION,SALT,DEHYDRATION,106,150-155,SALT addition.,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805261,7/13/2014 12:08:10,,1321852728,7/13/2014 12:07:59,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,106,150,,,117,154,DEHYDRATION,SALT,DEHYDRATION,106,150-155,SALT addition.,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805261,7/13/2014 12:12:05,,1321854018,7/13/2014 12:11:47,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,106,150,,,117,154,DEHYDRATION,SALT,DEHYDRATION,106,150,SALT,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805261,7/13/2014 12:12:14,,1321854037,7/13/2014 12:11:44,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,106,150,,,117,154,DEHYDRATION,SALT,the lack of DEHYDRATION,94-98-103-106,106-123-134-146-150-155-118,dehydration with increasing temperature and SALT addition.,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition.,106,150,106,150,117,154,1,RO-may_prevent,907161,The most significant results of this study are the level of hydration of the PC headgroup and the lack of dehydration with increasing temperature and salt addition,dehydration,salt
502805262,7/13/2014 11:36:29,,1321840765,7/13/2014 11:36:03,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,CORNEA,57,35-44,PUNCTATE KERATITIS,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805262,7/13/2014 11:38:18,,1321841351,7/13/2014 11:38:02,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,punctate keratitis in CORNEA,35-44-54-57,8-19-31-35-44-54-57,epithelial infiltrates and PUNCTATE KERATITIS in cornea,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805262,7/13/2014 11:48:46,,1321845539,7/13/2014 11:47:56,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,CORNEA stain,57-64,35-44,PUNCTATE KERATITIS,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805262,7/13/2014 11:49:09,,1321845670,7/13/2014 11:48:12,vivatic,1.0,25451531,GBR,"","",83.67.28.193,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,punctate keratitis in CORNEA,35-44-54-57,35-44,PUNCTATE KERATITIS,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805262,7/13/2014 12:02:06,,1321850706,7/13/2014 12:01:35,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,CORNEA,57,35-44,PUNCTATE KERATITIS,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805262,7/13/2014 12:02:19,,1321850787,7/13/2014 12:02:02,neodev,1.0,18755947,GBR,H2,Accrington,80.47.185.52,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,punctate keratitis in CORNEA,35-44-57-54,35-44-54-57,PUNCTATE KERATITIS in cornea,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805262,7/13/2014 12:03:00,,1321850969,7/13/2014 12:02:43,instagc,1.0,13763729,USA,"","",75.182.89.225,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,CORNEA,57,35-44,PUNCTATE KERATITIS,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805262,7/13/2014 12:07:06,,1321852344,7/13/2014 12:06:41,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,CORNEA,57,35-44,PUNCTATE KERATITIS,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805262,7/13/2014 12:10:22,,1321853490,7/13/2014 12:09:44,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,CORNEA,57,35-44,PUNCTATE KERATITIS,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805262,7/13/2014 12:13:22,,1321854398,7/13/2014 12:11:59,instagc,1.0,19378092,USA,PA,Reading,174.55.181.238,57,35,,,63,53,CORNEA,PUNCTATE KERATITIS,punctate keratitis CORNEA,35-44-57,35-44,PUNCTATE KERATITIS,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye.,57,35 44,57,35,63,53,1,RO-has_finding_site,905383,? Acute epithelial infiltrates and punctate keratitis in cornea stain green with fluorescein dye,cornea,punctate keratitis
502805263,7/13/2014 11:29:55,,1321838155,7/13/2014 11:29:48,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"choice for treating uncomplicated GONORRHEA, as well as",94-98-107-121-132-135-140-87,132-135-140-143-157-161-121,"gonorrhea, as well as SPECTINOMYCIN and ceftriaxone.","The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805263,7/13/2014 11:39:49,,1321841968,7/13/2014 11:39:34,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"uncomplicated GONORRHEA,",107-121,143-157-161,SPECTINOMYCIN and ceftriaxone.,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805263,7/13/2014 11:42:52,,1321843354,7/13/2014 11:42:36,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"GONORRHEA,",121,143,SPECTINOMYCIN,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805263,7/13/2014 11:47:55,,1321845236,7/13/2014 11:47:35,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"GONORRHEA,",121,143,SPECTINOMYCIN,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805263,7/13/2014 11:50:44,,1321846240,7/13/2014 11:50:21,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"GONORRHEA,",121,143,SPECTINOMYCIN,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805263,7/13/2014 11:56:28,,1321848453,7/13/2014 11:55:41,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"uncomplicated GONORRHEA, as",107-121-140,143-157-161,SPECTINOMYCIN and ceftriaxone.,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805263,7/13/2014 11:57:08,,1321848675,7/13/2014 11:56:48,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"GONORRHEA,",121,143-161-121,"gonorrhea, SPECTINOMYCIN ceftriaxone.","The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805263,7/13/2014 11:57:53,,1321848966,7/13/2014 11:57:40,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"uncomplicated GONORRHEA,",107-121,143,SPECTINOMYCIN,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805263,7/13/2014 11:59:23,,1321849591,7/13/2014 11:58:26,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"uncomplicated GONORRHEA,",107-121,143-161,SPECTINOMYCIN ceftriaxone.,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805263,7/13/2014 11:59:42,,1321849736,7/13/2014 11:59:05,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,121,143,,,130,156,GONORRHEA,SPECTINOMYCIN,"uncomplicated GONORRHEA,",107-121,143,SPECTINOMYCIN,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone.",121,143,121,143,130,156,1,RO-may_treat,908238,"The control strains exhibited considerable sensitivity to ofloxacin, the antibiotic of choice for treating uncomplicated gonorrhea, as well as spectinomycin and ceftriaxone",gonorrhea,spectinomycin
502805264,7/13/2014 11:33:42,,1321839707,7/13/2014 11:32:29,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,SARS COV receptor,264-269-273,196-203-209-221-230-235-236,"SEVERE ACUTE RESPIRATORY SYNDROME (SARS - CoV),","To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805264,7/13/2014 11:35:25,,1321840368,7/13/2014 11:34:59,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,SARS COV,264-269,196-203-209-221-230-236,"SEVERE ACUTE RESPIRATORY SYNDROME (SARS CoV),","To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805264,7/13/2014 11:41:52,,1321842885,7/13/2014 11:41:33,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,coding for the SARS COV receptor,249-256-260-264-269-273,172-176-188-196-203-209-221-236-242-230,"the Coronavirus causing SEVERE ACUTE RESPIRATORY SYNDROME (SARS CoV), a","To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805264,7/13/2014 11:51:38,,1321846565,7/13/2014 11:51:09,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,coding for the SARS COV receptor,249-256-260-264-269-273,176-188-196-203-209-221,Coronavirus causing SEVERE ACUTE RESPIRATORY SYNDROME,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805264,7/13/2014 11:53:27,,1321847255,7/13/2014 11:53:00,vivatic,1.0,25451531,GBR,"","",83.67.28.193,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,SARS COV receptor,264-269-273,196-203-209-221-230-236,"SEVERE ACUTE RESPIRATORY SYNDROME (SARS CoV),","To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805264,7/13/2014 11:56:42,,1321848563,7/13/2014 11:56:24,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,SARS COV receptor,264-269-273,196-203-209-221,SEVERE ACUTE RESPIRATORY SYNDROME,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805264,7/13/2014 11:58:33,,1321849250,7/13/2014 11:57:51,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,SARS COV receptor,264-269-273,196-203-209-221,SEVERE ACUTE RESPIRATORY SYNDROME,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805264,7/13/2014 12:06:31,,1321852183,7/13/2014 12:06:15,instagc,1.0,13763729,USA,"","",75.182.89.225,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,SARS COV receptor,264-269-273,196-203-209-221,SEVERE ACUTE RESPIRATORY SYNDROME,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805264,7/13/2014 12:06:56,,1321852294,7/13/2014 12:06:35,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,SARS COV receptor,264-269-273,196-203-209-221,SEVERE ACUTE RESPIRATORY SYNDROME,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805264,7/13/2014 12:08:05,,1321852710,7/13/2014 12:07:44,neodev,1.0,18517457,GBR,"","",86.29.147.112,264,196,,,272,229,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,SARS COV receptor,264-269-273,196-203-209-221-230-236,"SEVERE ACUTE RESPIRATORY SYNDROME (SARS CoV),","To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB.",264 269,196 203 209 221,264,196,272,229,-1,RO-has_causative_agent,903575,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing severe acute respiratory syndrome (SARS-CoV), a gene coding for the SARS-CoV receptor or the genes coding for an antibody shown to bind and neutralize SARS-CoV (SARS-AB",SARS-CoV,severe acute respiratory syndrome
502805265,7/13/2014 11:40:29,,1321842292,7/13/2014 11:40:16,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,77,152,,,82,160,DRUGS,OVERDOSE,"DRUGS,",77,152,OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805265,7/13/2014 11:40:43,,1321842388,7/13/2014 11:40:26,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,77,152,,,82,160,DRUGS,OVERDOSE,"DRUGS,",77,152,OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805265,7/13/2014 11:43:09,,1321843485,7/13/2014 11:42:54,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,77,152,,,82,160,DRUGS,OVERDOSE,"DRUGS,",77,152,OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805265,7/13/2014 11:51:56,,1321846696,7/13/2014 11:51:53,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,77,152,,,82,160,DRUGS,OVERDOSE,"only a few DRUGS, and improved outcome",66-71-73-77-84-88-97,131-144-148-152,conclusively for any OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805265,7/13/2014 11:54:10,,1321847557,7/13/2014 11:53:54,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,77,152,,,82,160,DRUGS,OVERDOSE,"DRUGS,",77,152,OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805265,7/13/2014 11:56:38,,1321848522,7/13/2014 11:56:27,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,77,152,,,82,160,DRUGS,OVERDOSE,"DRUGS,",77,152,OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805265,7/13/2014 11:56:59,,1321848633,7/13/2014 11:56:41,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,77,152,,,82,160,DRUGS,OVERDOSE,"DRUGS,",77,152,OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805265,7/13/2014 12:05:47,,1321851874,7/13/2014 12:05:27,instagc,1.0,13763729,USA,"","",75.182.89.225,77,152,,,82,160,DRUGS,OVERDOSE,"DRUGS,",77,152,OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805265,7/13/2014 12:07:51,,1321852591,7/13/2014 12:07:34,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,77,152,,,82,160,DRUGS,OVERDOSE,"DRUGS,",77,152,OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805265,7/13/2014 12:08:44,,1321852865,7/13/2014 12:07:42,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,77,152,,,82,160,DRUGS,OVERDOSE,"DRUGS,",77,152,OVERDOSE.,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose.",77,152,77,152,82,160,-1,RO-has_causative_agent,903898,"However, increased drug clearance has been shown definitively for only a few drugs, and improved outcome has not been demonstrated conclusively for any overdose",drugs,overdose
502805266,7/13/2014 11:29:31,,1321837979,7/13/2014 11:29:15,clixsense,1.0,24763049,GBR,"","",86.133.47.213,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,has a more AGGRESSIVE CLINICAL COURSE.,61-65-67-72-83-92,0-9-16-21-34-39,Blastoid MANTLE CELL LYMPHOMA MCL) is,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805266,7/13/2014 11:37:33,,1321841115,7/13/2014 11:37:21,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,AGGRESSIVE CLINICAL COURSE.,72-83-92,0-9-16-21-30-34,Blastoid MANTLE CELL LYMPHOMA (BV MCL),Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805266,7/13/2014 11:39:35,,1321841892,7/13/2014 11:39:13,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,AGGRESSIVE CLINICAL COURSE.,72-83-92,0-9-16-21-30-33-34,Blastoid MANTLE CELL LYMPHOMA (BV - MCL),Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805266,7/13/2014 11:43:41,,1321843700,7/13/2014 11:43:26,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,AGGRESSIVE CLINICAL COURSE.,72-83-92,9-16-21,MANTLE CELL LYMPHOMA,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805266,7/13/2014 11:51:54,,1321846675,7/13/2014 11:51:19,vivatic,1.0,25451531,GBR,"","",83.67.28.193,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,AGGRESSIVE CLINICAL COURSE.,72-83-92,0-9-16-21-30-34,Blastoid MANTLE CELL LYMPHOMA (BV MCL),Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805266,7/13/2014 11:53:51,,1321847443,7/13/2014 11:53:35,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,AGGRESSIVE CLINICAL COURSE.,72-83-92,0-9-16-21,Blastoid MANTLE CELL LYMPHOMA,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805266,7/13/2014 11:55:55,,1321848226,7/13/2014 11:55:45,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,AGGRESSIVE CLINICAL COURSE.,72-83-92,0-9-16-21-30-34,Blastoid MANTLE CELL LYMPHOMA (BV MCL),Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805266,7/13/2014 12:02:00,,1321850640,7/13/2014 12:01:47,neodev,1.0,18755947,GBR,H2,Accrington,80.47.185.52,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,AGGRESSIVE CLINICAL COURSE.,72-83-92,0-9-16-21,Blastoid MANTLE CELL LYMPHOMA,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805266,7/13/2014 12:04:47,,1321851526,7/13/2014 12:04:35,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,AGGRESSIVE CLINICAL COURSE.,72-83-92,0-9-16-21,Blastoid MANTLE CELL LYMPHOMA,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805266,7/13/2014 12:06:32,,1321852184,7/13/2014 12:06:15,neodev,1.0,18517457,GBR,"","",86.29.147.112,72,9,,,98,29,AGGRESSIVE CLINICAL COURSE,MANTLE CELL LYMPHOMA,AGGRESSIVE CLINICAL COURSE.,72-83-92,0-9-16-21-30-34,Blastoid MANTLE CELL LYMPHOMA (BV MCL),Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course.,72 83 92,9 16 21,72,9,98,29,1,RO-disease_may_have_finding,902768,Blastoid mantle cell lymphoma (BV-MCL) is a rare variant and has a more aggressive clinical course,aggressive clinical course,mantle cell lymphoma
502805267,7/13/2014 11:29:32,,1321837982,7/13/2014 11:28:41,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"the tumor causes bloody ASCITES, shock, or peritonitis,",32-38-45-52-61-68-71-28,101-107-121-124-139-94,be first manifestation of HEPATOCELLULAR CARCINOMA.,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805267,7/13/2014 11:36:45,,1321840887,7/13/2014 11:36:35,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"tumor causes bloody ASCITES, shock, or peritonitis,",32-38-45-52-61-68-71,124-139,HEPATOCELLULAR CARCINOMA.,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805267,7/13/2014 11:46:53,,1321844868,7/13/2014 11:46:34,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",52,124-139,HEPATOCELLULAR CARCINOMA.,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805267,7/13/2014 11:49:39,,1321845863,7/13/2014 11:49:10,vivatic,1.0,25451531,GBR,"","",83.67.28.193,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES, shock,",52-61,124-139,HEPATOCELLULAR CARCINOMA.,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805267,7/13/2014 11:55:11,,1321847901,7/13/2014 11:54:52,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"bloody ASCITES,",45-52,121-124-139-107,manifestation of HEPATOCELLULAR CARCINOMA.,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805267,7/13/2014 11:55:13,,1321847913,7/13/2014 11:54:50,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"tumor ASCITES, peritonitis, hepatocellular carcinoma.",32-52-71-124-139,124-139-71,"peritonitis, HEPATOCELLULAR CARCINOMA.","Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805267,7/13/2014 11:57:12,,1321848716,7/13/2014 11:56:54,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",52,124-139,HEPATOCELLULAR CARCINOMA.,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805267,7/13/2014 12:02:22,,1321850799,7/13/2014 12:02:08,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"bloody ASCITES, shock,",45-52-61,124-139,HEPATOCELLULAR CARCINOMA.,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805267,7/13/2014 12:02:31,,1321850823,7/13/2014 12:02:14,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"bloody ASCITES, peritonitis,",45-52-71,124-139,HEPATOCELLULAR CARCINOMA.,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805267,7/13/2014 12:04:05,,1321851306,7/13/2014 12:03:44,neodev,1.0,18517457,GBR,"","",86.29.147.112,52,124,,,59,148,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",52,124-139,HEPATOCELLULAR CARCINOMA.,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma.",52,124 139,52,124,59,148,1,RO-disease_may_have_finding,902829,"Occasionally, hemorrhage of the tumor causes bloody ascites, shock, or peritonitis, which may be the first manifestation of hepatocellular carcinoma",ascites,hepatocellular carcinoma
502805268,7/13/2014 11:27:49,,1321837366,7/13/2014 11:27:44,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,131,114,,,139,126,LEUKEMIA,METHOTREXATE,treated with methotrexate for LEUKEMIA 58 or treated,109-114-127-131-141-146-149-101,92-101-109-114-127-131-141-80,survival patients treated with METHOTREXATE for leukemia 58,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805268,7/13/2014 11:41:52,,1321842888,7/13/2014 11:41:44,clixsense,1.0,24763049,GBR,"","",86.133.47.213,131,114,,,139,126,LEUKEMIA,METHOTREXATE,with methotrexate for LEUKEMIA 58 or treated,109-114-127-131-141-146-149,92-101-109-114-127-131-141,patients treated with METHOTREXATE for leukemia 58,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805268,7/13/2014 11:47:22,,1321845011,7/13/2014 11:47:07,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,131,114,,,139,126,LEUKEMIA,METHOTREXATE,methotrexate for LEUKEMIA 58,114-127-131-141,114-127-131-141,METHOTREXATE for leukemia 58,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805268,7/13/2014 11:52:19,,1321846879,7/13/2014 11:52:02,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,131,114,,,139,126,LEUKEMIA,METHOTREXATE,LEUKEMIA,131,114,METHOTREXATE,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805268,7/13/2014 11:52:42,,1321847025,7/13/2014 11:52:40,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,131,114,,,139,126,LEUKEMIA,METHOTREXATE,with methotrexate for LEUKEMIA 58 or treated,109-114-127-131-141-146-149,92-101-109-114-127-131-141,patients treated with METHOTREXATE for leukemia 58,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805268,7/13/2014 11:58:37,,1321849278,7/13/2014 11:57:15,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,131,114,,,139,126,LEUKEMIA,METHOTREXATE,LEUKEMIA 58,131-141,114-127-131-141,METHOTREXATE for leukemia 58,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805268,7/13/2014 12:01:20,,1321850367,7/13/2014 12:01:05,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,131,114,,,139,126,LEUKEMIA,METHOTREXATE,LEUKEMIA 58,131-141,114,METHOTREXATE,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805268,7/13/2014 12:05:41,,1321851839,7/13/2014 12:05:22,neodev,1.0,18517457,GBR,"","",86.29.147.112,131,114,,,139,126,LEUKEMIA,METHOTREXATE,LEUKEMIA 58,131-141,114,METHOTREXATE,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805268,7/13/2014 12:06:40,,1321852206,7/13/2014 12:06:20,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,131,114,,,139,126,LEUKEMIA,METHOTREXATE,LEUKEMIA,131,114,METHOTREXATE,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805268,7/13/2014 12:14:10,,1321854714,7/13/2014 12:13:22,instagc,1.0,19378092,USA,PA,Reading,174.55.181.238,131,114,,,139,126,LEUKEMIA,METHOTREXATE,LEUKEMIA 58,131-141,114-131-141,METHOTREXATE leukemia 58,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer.",131,114,131,114,139,126,1,RO-may_treat,907542,"For example, certain polymorphisms in the  TS  gene are associated with reduced survival in patients treated with methotrexate for leukemia  58   or treated with 5-FU for colorectal cancer",leukemia,methotrexate
502805269,7/13/2014 11:37:16,,1321841045,7/13/2014 11:36:24,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,85-101-112,BALSALAZIDE ulcerative colitis,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805269,7/13/2014 11:53:11,,1321847198,7/13/2014 11:52:51,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,85,BALSALAZIDE,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805269,7/13/2014 11:58:16,,1321849111,7/13/2014 11:57:56,vivatic,1.0,25451531,GBR,"","",83.67.28.193,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,85,BALSALAZIDE,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805269,7/13/2014 12:02:37,,1321850848,7/13/2014 12:02:20,neodev,1.0,18755947,GBR,H2,Accrington,80.47.185.52,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,85,BALSALAZIDE,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805269,7/13/2014 12:03:51,,1321851242,7/13/2014 12:03:30,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,85,BALSALAZIDE,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805269,7/13/2014 12:06:19,,1321852096,7/13/2014 12:05:53,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,85,BALSALAZIDE,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805269,7/13/2014 12:06:49,,1321852254,7/13/2014 12:06:32,instagc,1.0,13763729,USA,"","",75.182.89.225,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,85,BALSALAZIDE,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805269,7/13/2014 12:08:06,,1321852720,7/13/2014 12:07:39,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,67-70-81-85-97-101-112-63,use of mesalamine and BALSALAZIDE for ulcerative colitis,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805269,7/13/2014 12:10:44,,1321853577,7/13/2014 12:10:28,neodev,1.0,18517457,GBR,"","",86.29.147.112,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,85,BALSALAZIDE,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805269,7/13/2014 12:13:35,,1321854473,7/13/2014 12:12:59,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,101,85,,,119,96,ULCERATIVE COLITIS,BALSALAZIDE,ULCERATIVE COLITIS,101-112,85,BALSALAZIDE,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD.",101 112,85,101,85,119,96,1,RO-may_treat,908219,"Medications associated with PPD are reviewed and the patient's use of mesalamine and balsalazide for ulcerative colitis are deemed potential triggers, given their relative similarity to aspirin, a known trigger of PPD",ulcerative colitis,balsalazide
502805270,7/13/2014 11:32:38,,1321839232,7/13/2014 11:32:30,clixsense,1.0,24763049,GBR,"","",86.133.47.213,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS is a,0-6-20-45-48,55-64-72-75-81,clinical variant of LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805270,7/13/2014 11:36:55,,1321840920,7/13/2014 11:36:47,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS,0-6-20,55-64-72-75-81,clinical variant of LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805270,7/13/2014 11:49:30,,1321845806,7/13/2014 11:49:15,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS,0-6-20,75-81,LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805270,7/13/2014 11:53:53,,1321847425,7/13/2014 11:53:42,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS (panniculitis),0-6-20-30,75-81,LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805270,7/13/2014 11:54:59,,1321847837,7/13/2014 11:54:36,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS (panniculitis),0-6-20-30,75-81,LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805270,7/13/2014 11:58:23,,1321849170,7/13/2014 11:58:13,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS,0-6-20,75-81,LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805270,7/13/2014 12:04:17,,1321851376,7/13/2014 12:04:08,instagc,1.0,13763729,USA,"","",75.182.89.225,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS,0-6-20,75-81,LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805270,7/13/2014 12:05:52,,1321851909,7/13/2014 12:05:39,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS,0-6-20,75-81,LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805270,7/13/2014 12:10:27,,1321853544,7/13/2014 12:10:13,neodev,1.0,18517457,GBR,"","",86.29.147.112,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS (panniculitis),0-6-20-30,75-81,LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805270,7/13/2014 12:10:31,,1321853553,7/13/2014 12:10:16,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,0,75,,,29,94,LUPUS ERYTHEMATOSUS PROFUNDUS,LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS PROFUNDUS,0-6-20,75-81,LUPUS ERYTHEMATOSUS.,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus.,0 6 20,75 81,0,75,29,94,-1,RO-cause_of,900458,Lupus erythematosus profundus (panniculitis) is a rare clinical variant of lupus erythematosus,Lupus erythematosus profundus,lupus erythematosus
502805271,7/13/2014 11:51:39,,1321846567,7/13/2014 11:51:07,prodege,1,27934334,GBR,E4,Loughton,86.162.38.12,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,ALLERGIC RHINITIS; AR),92-101-111,31,ATOPIC,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805271,7/13/2014 11:52:47,,1321847058,7/13/2014 11:52:44,prodege,1,12944140,GBR,I4,Mitcham,92.21.66.102,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,"bronchial asthma; BA, ALLERGIC RHINITIS; AR) in Japanese",70-80-88-92-101-111-115-118,14-23-28-31-38-54,relative risk of ATOPIC disease dermatitis;,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805271,7/13/2014 11:54:35,,1321847741,7/13/2014 11:53:52,sendearnings,1,11896941,USA,FL,Seminole,97.106.105.251,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,ALLERGIC RHINITIS;,92-101,31-38,ATOPIC disease,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805271,7/13/2014 12:00:11,,1321849919,7/13/2014 11:59:37,vivatic,1,25451531,GBR,"","",83.67.28.193,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,ALLERGIC RHINITIS; AR),92-101-111,31-38-46-54-66-70-80-88-92-101-111,"ATOPIC disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR)","Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805271,7/13/2014 12:02:19,,1321850789,7/13/2014 12:02:05,instagc,1,13763729,USA,"","",75.182.89.225,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,ALLERGIC RHINITIS; in,92-101-115,31,ATOPIC,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805271,7/13/2014 12:10:15,,1321853456,7/13/2014 12:09:53,prodege,1,22360212,GBR,I1,Luton,82.6.41.191,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,ALLERGIC RHINITIS;,92-101,31-38,ATOPIC disease,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805271,7/13/2014 12:11:42,,1321853878,7/13/2014 12:10:42,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,"atopic disease (atopic dermatitis; AD, bronchial asthma; BA, ALLERGIC RHINITIS; AR)",31-38-46-54-70-80-88-92-101-111-66,23-28-31-38-46-54-66-70-80-88-92-101-111,"risk of ATOPIC disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR)","Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805271,7/13/2014 12:11:45,,1321853895,7/13/2014 12:11:08,gifthulk,1,25566511,USA,"","",24.164.11.173,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,ALLERGIC RHINITIS;,92-101,31-38,ATOPIC disease,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805271,7/13/2014 12:14:32,,1321854821,7/13/2014 12:14:03,clixsense,1,26889820,GBR,C3,Shelford,92.18.120.203,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,ALLERGIC RHINITIS; AR),92-101-111,31-38,ATOPIC disease,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805271,7/13/2014 12:15:11,,1321855017,7/13/2014 12:13:36,clixsense,1,8769423,AUS,06,Launceston,121.223.145.102,92,31,,,109,37,ALLERGIC RHINITIS,ATOPIC,"bronchial asthma; BA, ALLERGIC RHINITIS; AR)",70-80-88-92-101-111,31-38,ATOPIC disease,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993.",92 101,31,92,31,109,37,-1,RO-cause_of,900077,"Incidence and relative risk of atopic disease (atopic dermatitis; AD, bronchial asthma; BA, allergic rhinitis; AR) in Japanese infants and children in relation to their nutrition in infancy was analyzed from the data of the epidemiological survey which was conducted for 10,000 mothers of infants and children in 1993",allergic rhinitis,atopic
502805272,7/13/2014 11:32:19,,1321839053,7/13/2014 11:32:03,clixsense,1.0,24763049,GBR,"","",86.133.47.213,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,of scrapes with SEVERE DYSPLASIA and carcinoma in,318-321-329-334-341-351-355-365,334-341-351-355-365-368,severe dysplasia and CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805272,7/13/2014 11:37:41,,1321841156,7/13/2014 11:37:18,clixsense,1,27969116,NLD,04,Veendam,185.12.216.74,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,SEVERE DYSPLASIA carcinoma in situ.,334-341-355-365-368,341-355-365-368,dysplasia CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805272,7/13/2014 11:55:20,,1321847964,7/13/2014 11:55:08,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,SEVERE DYSPLASIA,334-341,334-341-351-355-365-368,severe dysplasia and CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805272,7/13/2014 11:56:47,,1321848596,7/13/2014 11:56:27,vivatic,1.0,25451531,GBR,"","",83.67.28.193,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,SEVERE DYSPLASIA,334-341,355-365-368,CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805272,7/13/2014 12:00:58,,1321850263,7/13/2014 12:00:49,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,SEVERE DYSPLASIA,334-341,355-365-368,CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805272,7/13/2014 12:02:48,,1321850896,7/13/2014 12:02:32,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,of SEVERE DYSPLASIA and carcinoma in situ.,318-334-341-351-355-365-368,334-341-351-355-365-368,severe dysplasia and CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805272,7/13/2014 12:05:48,,1321851878,7/13/2014 12:05:21,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,SEVERE DYSPLASIA,334-341,355-365-368,CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805272,7/13/2014 12:09:07,,1321853026,7/13/2014 12:08:50,neodev,1,18517457,GBR,"","",86.29.147.112,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,SEVERE DYSPLASIA,334-341,355-365-368,CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805272,7/13/2014 12:10:41,,1321853565,7/13/2014 12:10:22,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,scrapes with SEVERE DYSPLASIA and carcinoma in situ.,321-329-334-341-351-355-365-368,321-334-341-351-355-365-368-329,scrapes with severe dysplasia and CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805272,7/13/2014 12:12:25,,1321854059,7/13/2014 12:11:45,gifthulk,1.0,25566511,USA,"","",24.164.11.173,334,355,,,350,372,SEVERE DYSPLASIA,CARCINOMA IN SITU,SEVERE DYSPLASIA and carcinoma,334-341-351-355,355-365-368,CARCINOMA IN SITU.,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ.",334 341,355 365 368,334,355,350,372,-1,RO-disease_has_finding,901566,"HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ",severe dysplasia,carcinoma in situ
502805273,7/13/2014 11:30:14,,1321838287,7/13/2014 11:30:09,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,149,211,,,154,217,PAINS,ANGINA,"pains, between these laboratory PAINS and an idiopathic",124-132-138-149-155-159-162-106,191-194-203-211-218-221-225-106,"pains, to exercise induced ANGINA in the patients.","Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805273,7/13/2014 11:37:06,,1321840983,7/13/2014 11:36:44,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,149,211,,,154,217,PAINS,ANGINA,PAINS,149,211,ANGINA,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805273,7/13/2014 11:49:16,,1321845688,7/13/2014 11:48:47,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,149,211,,,154,217,PAINS,ANGINA,PAINS,149,211,ANGINA,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805273,7/13/2014 11:51:20,,1321846432,7/13/2014 11:51:02,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,149,211,,,154,217,PAINS,ANGINA,these PAINS,132-149,211,ANGINA,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805273,7/13/2014 11:54:36,,1321847743,7/13/2014 11:54:07,vivatic,1.0,25451531,GBR,"","",83.67.28.193,149,211,,,154,217,PAINS,ANGINA,PAINS,149,194-203-211,exercise induced ANGINA,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805273,7/13/2014 12:01:15,,1321850327,7/13/2014 12:00:42,neodev,1.0,18755947,GBR,H2,Accrington,80.47.185.52,149,211,,,154,217,PAINS,ANGINA,PAINS,149,194-203-211,exercise induced ANGINA,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805273,7/13/2014 12:08:53,,1321852957,7/13/2014 12:08:29,instagc,1.0,13763729,USA,"","",75.182.89.225,149,211,,,154,217,PAINS,ANGINA,laboratory PAINS,149-138,194-203-211,exercise induced ANGINA,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805273,7/13/2014 12:12:21,,1321854042,7/13/2014 12:11:42,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,149,211,,,154,217,PAINS,ANGINA,PAINS,149,211,ANGINA,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805273,7/13/2014 12:12:55,,1321854173,7/13/2014 12:12:26,gifthulk,1.0,25566511,USA,"","",24.164.11.173,149,211,,,154,217,PAINS,ANGINA,"laboratory PAINS and idiopathic pain,",138-149-155-162-173,194-203-211,exercise induced ANGINA,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805273,7/13/2014 12:13:18,,1321854347,7/13/2014 12:12:25,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,149,211,,,154,217,PAINS,ANGINA,PAINS,149,194-203-211,exercise induced ANGINA,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients.",149,211,149,211,154,217,-1,RO-has_definitional_manifestation,904623,"Results showed near-zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory pains and an idiopathic pain, the latency to exercise-induced angina in the patients",pains,angina
502805274,7/13/2014 11:28:24,,1321837580,7/13/2014 11:28:19,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,deficiency the rate of IRON DEFICIENCY ANEMIA was 0.94%.,73-77-82-85-90-101-108-112-48,25-29-40-43-48-59-63-69-73,the prevalence of IRON DEFICIENCY was 4.94% and the,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805274,7/13/2014 11:41:47,,1321842812,7/13/2014 11:41:32,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,IRON DEFICIENCY ANEMIA,85-90-101,43-48,IRON DEFICIENCY,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805274,7/13/2014 11:42:43,,1321843319,7/13/2014 11:42:02,clixsense,1.0,24763049,GBR,"","",86.133.47.213,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,the rate of IRON DEFICIENCY ANEMIA was 0.94%.,73-77-82-85-90-101-108-112,25-29-40-43-48-59-63-69,the prevalence of IRON DEFICIENCY was 4.94% and,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805274,7/13/2014 11:47:11,,1321844981,7/13/2014 11:46:55,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,IRON DEFICIENCY ANEMIA,85-90-101,43-48,IRON DEFICIENCY,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805274,7/13/2014 11:47:27,,1321845040,7/13/2014 11:47:08,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,IRON DEFICIENCY ANEMIA,85-90-101,43-48,IRON DEFICIENCY,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805274,7/13/2014 11:51:00,,1321846323,7/13/2014 11:50:45,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,IRON DEFICIENCY ANEMIA,85-90-101,43-48,IRON DEFICIENCY,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805274,7/13/2014 11:53:05,,1321847176,7/13/2014 11:53:03,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,the rate of IRON DEFICIENCY ANEMIA was 0.94%.,73-77-82-85-90-101-108-112,25-29-40-43-48-59-63-69,the prevalence of IRON DEFICIENCY was 4.94% and,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805274,7/13/2014 11:54:35,,1321847734,7/13/2014 11:54:17,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,IRON DEFICIENCY ANEMIA,85-90-101,43-48,IRON DEFICIENCY,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805274,7/13/2014 11:56:03,,1321848302,7/13/2014 11:55:46,vivatic,1.0,25451531,GBR,"","",83.67.28.193,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,IRON DEFICIENCY ANEMIA,85-90-101,43-48,IRON DEFICIENCY,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805274,7/13/2014 12:09:58,,1321853379,7/13/2014 12:09:43,instagc,1.0,13763729,USA,"","",75.182.89.225,85,43,,,107,58,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY,IRON DEFICIENCY ANEMIA,85-90-101,43-48,IRON DEFICIENCY,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%.",85 90 101,43 48,85,43,107,58,-1,RO-cause_of,900489,"In our study population, the prevalence of iron deficiency was 4.94% and the rate of iron deficiency anemia was 0.94%",iron deficiency anemia,iron deficiency
502805275,7/13/2014 11:27:35,,1321837280,7/13/2014 11:27:28,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,in diagnosing suspected ALLERGIC CONTACT DERMATITIS when hypersensitivity to other,67-70-81-91-100-108-119-124-141-144,100-108-119-124-141-144-150-91,allergic contact dermatitis when HYPERSENSITIVITY to other topical,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805275,7/13/2014 11:51:23,,1321846446,7/13/2014 11:51:20,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,in diagnosing suspected ALLERGIC CONTACT DERMATITIS when hypersensitivity to,67-70-81-91-100-108-119-124-141,100-108-119-124-141-144-150,contact dermatitis when HYPERSENSITIVITY to other topical,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805275,7/13/2014 11:53:49,,1321847417,7/13/2014 11:53:28,vivatic,1.0,25451531,GBR,"","",83.67.28.193,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,ALLERGIC CONTACT DERMATITIS,91-100-108,124,HYPERSENSITIVITY,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805275,7/13/2014 11:57:37,,1321848849,7/13/2014 11:57:25,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,ALLERGIC CONTACT DERMATITIS,91-100-108,124,HYPERSENSITIVITY,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805275,7/13/2014 12:04:09,,1321851329,7/13/2014 12:03:47,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,diagnosing suspected ALLERGIC CONTACT DERMATITIS,70-81-91-100-108,124,HYPERSENSITIVITY,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805275,7/13/2014 12:05:20,,1321851721,7/13/2014 12:05:00,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,ALLERGIC CONTACT DERMATITIS,91-100-108,124,HYPERSENSITIVITY,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805275,7/13/2014 12:07:52,,1321852613,7/13/2014 12:07:37,instagc,1.0,13763729,USA,"","",75.182.89.225,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,ALLERGIC CONTACT DERMATITIS,91-100-108,124,HYPERSENSITIVITY,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805275,7/13/2014 12:09:07,,1321853016,7/13/2014 12:08:49,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,ALLERGIC CONTACT DERMATITIS,91-100-108,108-124-100,contact dermatitis HYPERSENSITIVITY,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805275,7/13/2014 12:09:54,,1321853346,7/13/2014 12:09:35,neodev,1.0,18517457,GBR,"","",86.29.147.112,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,ALLERGIC CONTACT DERMATITIS,91-100-108,124,HYPERSENSITIVITY,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805275,7/13/2014 12:13:22,,1321854422,7/13/2014 12:12:15,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,91,124,,,118,140,ALLERGIC CONTACT DERMATITIS,HYPERSENSITIVITY,diagnosing suspected ALLERGIC CONTACT DERMATITIS,70-81-91-100-108,124-141-144-150-158-170-177,"HYPERSENSITIVITY to other topical antibiotics (e.g., neomycin)","a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected.",91 100 108,124,91,124,118,140,-1,RO-cause_of,900279,"a  Patch testing (e.g., 1% bacitracin in petrolatum) may be useful in diagnosing suspected allergic contact dermatitis when hypersensitivity to other topical antibiotics (e.g., neomycin) is suspected",allergic contact dermatitis,hypersensitivity
502805276,7/13/2014 11:40:35,,1321842327,7/13/2014 11:40:02,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,40,0,,,45,14,TEETH,DENTAL PLAQUES,Dental plaques TEETH,0-7-40,0-7,DENTAL PLAQUES,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805276,7/13/2014 11:42:08,,1321843047,7/13/2014 11:41:53,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,40,0,,,45,14,TEETH,DENTAL PLAQUES,TEETH,40,0-7,DENTAL PLAQUES,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805276,7/13/2014 11:51:06,,1321846349,7/13/2014 11:50:42,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,40,0,,,45,14,TEETH,DENTAL PLAQUES,TEETH,40,0-7,DENTAL PLAQUES,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805276,7/13/2014 11:52:50,,1321847092,7/13/2014 11:52:39,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,40,0,,,45,14,TEETH,DENTAL PLAQUES,TEETH,40,0-7,DENTAL PLAQUES,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805276,7/13/2014 11:53:25,,1321847243,7/13/2014 11:53:11,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,40,0,,,45,14,TEETH,DENTAL PLAQUES,TEETH,40,0-7,DENTAL PLAQUES,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805276,7/13/2014 11:53:52,,1321847432,7/13/2014 11:53:22,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,40,0,,,45,14,TEETH,DENTAL PLAQUES,TEETH,40,0-7,DENTAL PLAQUES,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805276,7/13/2014 12:03:12,,1321851013,7/13/2014 12:02:49,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,40,0,,,45,14,TEETH,DENTAL PLAQUES,Dental plaques in TEETH,0-7-40-29,0-7,DENTAL PLAQUES,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805276,7/13/2014 12:03:20,,1321851088,7/13/2014 12:03:04,neodev,1.0,18517457,GBR,"","",86.29.147.112,40,0,,,45,14,TEETH,DENTAL PLAQUES,the TEETH,36-40,0-7,DENTAL PLAQUES,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805276,7/13/2014 12:07:20,,1321852461,7/13/2014 12:07:04,instagc,1.0,13763729,USA,"","",75.182.89.225,40,0,,,45,14,TEETH,DENTAL PLAQUES,TEETH,40,0-7,DENTAL PLAQUES,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805276,7/13/2014 12:08:42,,1321852863,7/13/2014 12:08:07,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,40,0,,,45,14,TEETH,DENTAL PLAQUES,Dental plaques in all the TEETH,0-7-29-32-36-40,0-7-29-32-36-40,DENTAL PLAQUES in all the teeth,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth.",40,0 7,40,0,45,14,1,RO-has_finding_site,905216,"Dental plaques were detected in all the teeth under investigation, with the exception of impacted teeth",teeth,Dental plaques
502805277,7/13/2014 11:35:17,,1321840333,7/13/2014 11:35:08,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,backscatter bacteremia bacteremia BACTERIA bacteria bacteria bacteria,355-369-381-394-404-415-425,404-415-425-436-446-457-467-479,bacteria bacteria bacteria BACTERIAL VAGINOSIS bacterial vaginosis bactericidal,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805277,7/13/2014 11:39:41,,1321841927,7/13/2014 11:39:22,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,BACTERIA,394,436-446,BACTERIAL VAGINOSIS,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805277,7/13/2014 11:44:18,,1321843918,7/13/2014 11:44:00,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,BACTERIA,394,436-446,BACTERIAL VAGINOSIS,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805277,7/13/2014 11:49:26,,1321845760,7/13/2014 11:48:22,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,BACTERIA,394,436-446,BACTERIAL VAGINOSIS,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805277,7/13/2014 11:54:15,,1321847587,7/13/2014 11:53:34,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,BACTERIA,394,436-446,BACTERIAL VAGINOSIS,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805277,7/13/2014 11:57:13,,1321848719,7/13/2014 11:56:29,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,BACTERIA,394,436-446,BACTERIAL VAGINOSIS,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805277,7/13/2014 12:02:42,,1321850859,7/13/2014 12:02:22,neodev,1.0,18517457,GBR,"","",86.29.147.112,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,BACTERIA,394,436-446,BACTERIAL VAGINOSIS,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805277,7/13/2014 12:05:03,,1321851632,7/13/2014 12:04:50,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,BACTERIA,394,436-446,BACTERIAL VAGINOSIS,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805277,7/13/2014 12:07:28,,1321852511,7/13/2014 12:07:07,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,BACTERIA,394,436-446,BACTERIAL VAGINOSIS,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805277,7/13/2014 12:09:33,,1321853211,7/13/2014 12:09:07,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,394,436,,,402,455,BACTERIA,BACTERIAL VAGINOSIS,BACTERIA,394,436-446,BACTERIAL VAGINOSIS,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis.",394,436 446,394,436,402,455,-1,RO-has_causative_agent,903751,"?-glucuronidase  ?-glucuronidase   Babbitt metal  Babbitt metal   Babcock's operation  Babcock's operation   Babesia  Babesia   babesiosis  babesiosis   Babinski's reflex  Babinski's reflex   bacciform  bacciform   Bacillaceae  Bacillaceae   bacillar  bacitracin  bacitracin   backache  backache   backbone  backbone   backcross  backcross   backscatter  backscatter   bacteremia  bacteremia   bacteria  bacteria   bacteria  bacteria   bacterial vaginosis  bacterial vaginosis   bactericidal  bacteriocin   bacteriogenic  bacteriogenic   bacteriohemagglutinin  bacteriohemagglutinin   bacteriohemolysin  bacteriohemolysin   bacteriologic  bacteriologic   bacteriologist  bacteriophytoma   bacterioprecipitin  bacterioprecipitin   bacterioprotein  bacterioprotein   bacteriopsonin  bacteriopsonin   bacteriosis  bacteriosis   bacteriostasis  bacteriostasis   bacteriuria   bacteroid  bacteroid   Bacteroides  Bacteroides   baculovirus  baculovirus   baffle  baffle   bagassosis  bagassosis   Bailey, Harriet  Bailey, Harriet   Bainbridge effect  Bainbridge effect   balanopreputial  balanopreputial   balanorrhagia  balanorrhagia   balantidial  balantidial   balantidiasis  balantidiasis",bacteria,bacterial vaginosis
502805278,7/13/2014 11:28:34,,1321837613,7/13/2014 11:28:25,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,"In pediatric patients, CUTANEOUS INVOLVEMENT is most prevalent in",0-3-13-23-33-45-48-53-63,66-70-75-78-88-100-106-109-63,"in the form of URTICARIA PIGMENTOSA, which is typically","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805278,7/13/2014 11:32:29,,1321839160,7/13/2014 11:32:20,clixsense,1.0,24763049,GBR,"","",86.133.47.213,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,"In pediatric patients, CUTANEOUS INVOLVEMENT is most prevalent",0-3-13-23-33-45-48-53,66-70-75-78-88-100-106-109,"the form of URTICARIA PIGMENTOSA, which is typically","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805278,7/13/2014 11:33:58,,1321839787,7/13/2014 11:33:41,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,CUTANEOUS INVOLVEMENT,23-33,78-88,"URTICARIA PIGMENTOSA,","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805278,7/13/2014 11:46:13,,1321844704,7/13/2014 11:45:54,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,CUTANEOUS INVOLVEMENT,23-33,78-88,"URTICARIA PIGMENTOSA,","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805278,7/13/2014 11:51:42,,1321846573,7/13/2014 11:51:17,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,pediatric CUTANEOUS INVOLVEMENT,3-23-33,78-88,"URTICARIA PIGMENTOSA,","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805278,7/13/2014 11:52:12,,1321846831,7/13/2014 11:52:10,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,"In pediatric patients, CUTANEOUS INVOLVEMENT is most prevalent",0-3-13-23-33-45-48-53,66-70-75-78-88-100-106-109,"the form of URTICARIA PIGMENTOSA, which is typically","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805278,7/13/2014 11:52:22,,1321846895,7/13/2014 11:52:08,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,CUTANEOUS INVOLVEMENT,23-33,78-88,"URTICARIA PIGMENTOSA,","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805278,7/13/2014 11:55:58,,1321848252,7/13/2014 11:55:41,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,CUTANEOUS INVOLVEMENT,23-33,78-88,"URTICARIA PIGMENTOSA,","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805278,7/13/2014 11:56:51,,1321848600,7/13/2014 11:55:12,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,CUTANEOUS INVOLVEMENT,23-33,66-70-75-78-88,"the form of URTICARIA PIGMENTOSA,","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805278,7/13/2014 11:56:55,,1321848634,7/13/2014 11:56:43,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,23,78,,,44,98,CUTANEOUS INVOLVEMENT,URTICARIA PIGMENTOSA,CUTANEOUS INVOLVEMENT,23-33,78-88,"URTICARIA PIGMENTOSA,","In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence.",23 33,78 88,23,78,44,98,1,RO-disease_has_finding,901944,"In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence",cutaneous involvement,urticaria pigmentosa
502805279,7/13/2014 11:30:09,,1321838259,7/13/2014 11:29:33,clixsense,1.0,24763049,GBR,"","",86.133.47.213,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,"microangiopathic hemolytic anemia, THROMBOCYTOPENIA and acute renal",63-80-90-98-115-119-125,50-54-60-63-80-90-98-115-119,"the triad of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia and acute","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805279,7/13/2014 11:40:44,,1321842406,7/13/2014 11:40:30,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,THROMBOCYTOPENIA,98,63-80-90,"MICROANGIOPATHIC HEMOLYTIC ANEMIA,","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805279,7/13/2014 11:44:55,,1321844117,7/13/2014 11:44:39,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,THROMBOCYTOPENIA,98,63-80-90,"MICROANGIOPATHIC HEMOLYTIC ANEMIA,","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805279,7/13/2014 11:51:32,,1321846523,7/13/2014 11:50:00,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,"microangiopathic hemolytic anemia, THROMBOCYTOPENIA",63-80-90-98,63-80-90-98-115-119-125-131,"MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia and acute renal failure.","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805279,7/13/2014 11:52:58,,1321847113,7/13/2014 11:52:55,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,"microangiopathic hemolytic anemia, THROMBOCYTOPENIA and acute renal",63-80-90-98-115-119-125,50-54-60-63-80-90-98-115-119,"the triad of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia and acute","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805279,7/13/2014 11:52:59,,1321847116,7/13/2014 11:52:35,vivatic,1.0,25451531,GBR,"","",83.67.28.193,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,THROMBOCYTOPENIA,98,63-80-90,"MICROANGIOPATHIC HEMOLYTIC ANEMIA,","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805279,7/13/2014 12:01:34,,1321850468,7/13/2014 12:01:21,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,"microangiopathic hemolytic anemia, THROMBOCYTOPENIA and acute renal",63-80-90-98-115-119-125,63-80-90-98-115-119-125-131,"MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia and acute renal failure.","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805279,7/13/2014 12:02:27,,1321850806,7/13/2014 12:02:05,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,microangiopathic THROMBOCYTOPENIA,63-98,50-54-60-63-80-90-119-125,"the triad of MICROANGIOPATHIC HEMOLYTIC ANEMIA, acute renal","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805279,7/13/2014 12:02:41,,1321850855,7/13/2014 12:02:17,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,THROMBOCYTOPENIA,98,63-80-90,"MICROANGIOPATHIC HEMOLYTIC ANEMIA,","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805279,7/13/2014 12:02:43,,1321850873,7/13/2014 12:02:08,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,98,63,,,114,96,THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA,THROMBOCYTOPENIA,98,63-80-90,"MICROANGIOPATHIC HEMOLYTIC ANEMIA,","The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.",98,63 80 90,98,63,114,96,-1,RO-has_manifestation,906262,"The hemolytic uremic syndrome is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure",thrombocytopenia,microangiopathic hemolytic anemia
502805280,7/13/2014 11:41:11,,1321842577,7/13/2014 11:40:46,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,160,74,,,172,83,YELLOW FEVER,PREGNANCY,YELLOW FEVER,160-167,74,PREGNANCY,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805280,7/13/2014 11:42:31,,1321843212,7/13/2014 11:41:58,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,160,74,,,172,83,YELLOW FEVER,PREGNANCY,YELLOW FEVER,160-167,74,PREGNANCY,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805280,7/13/2014 11:44:54,,1321844080,7/13/2014 11:44:45,clixsense,1.0,24763049,GBR,"","",86.133.47.213,160,74,,,172,83,YELLOW FEVER,PREGNANCY,postpone travel to YELLOW FEVER endemic areas until,141-150-157-160-167-173-181-187,59-62-67-74-84-87-92,be used during PREGNANCY in rare circumstances,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805280,7/13/2014 11:46:32,,1321844767,7/13/2014 11:46:15,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,160,74,,,172,83,YELLOW FEVER,PREGNANCY,YELLOW FEVER,160-167,74,PREGNANCY,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805280,7/13/2014 11:50:09,,1321845986,7/13/2014 11:49:40,vivatic,1.0,25451531,GBR,"","",83.67.28.193,160,74,,,172,83,YELLOW FEVER,PREGNANCY,YELLOW FEVER,160-167,74,PREGNANCY,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805280,7/13/2014 11:53:09,,1321847192,7/13/2014 11:53:07,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,160,74,,,172,83,YELLOW FEVER,PREGNANCY,postpone travel to YELLOW FEVER endemic areas until,141-150-157-160-167-173-181-187,59-62-67-74-84-87-92,be used during PREGNANCY in rare circumstances,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805280,7/13/2014 11:53:40,,1321847366,7/13/2014 11:53:27,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,160,74,,,172,83,YELLOW FEVER,PREGNANCY,YELLOW FEVER endemic,160-167-173,74,PREGNANCY,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805280,7/13/2014 11:56:47,,1321848595,7/13/2014 11:56:23,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,160,74,,,172,83,YELLOW FEVER,PREGNANCY,YELLOW FEVER,160-167,74-167-160,PREGNANCY yellow fever,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805280,7/13/2014 12:00:05,,1321849882,7/13/2014 11:59:43,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,160,74,,,172,83,YELLOW FEVER,PREGNANCY,YELLOW FEVER,160-167,74,PREGNANCY,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805280,7/13/2014 12:01:45,,1321850528,7/13/2014 12:01:17,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,160,74,,,172,83,YELLOW FEVER,PREGNANCY,YELLOW FEVER,160-167,74,PREGNANCY,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery.",160 167,74,160,74,172,83,1,RO-contraindicated_drug,901169,"106 ,   b   Advise such women that the vaccine should only be used during pregnancy in rare circumstances and that efforts should be made to postpone travel to yellow fever endemic areas until after delivery",yellow fever,pregnancy
502805281,7/13/2014 11:28:18,,1321837518,7/13/2014 11:28:09,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,48,14,,,55,22,ITCHING,PRURITUS,ani anal and perianal ITCHING.,30-35-39-48-23,0-9-14-23-27-30-35,PRURITUS ANI PRURITUS ani is anal and,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805281,7/13/2014 11:37:41,,1321841153,7/13/2014 11:37:29,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,48,14,,,55,22,ITCHING,PRURITUS,anal and perianal ITCHING.,30-35-39-48,0-9-14-23,PRURITUS ANI PRURITUS ani,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805281,7/13/2014 11:46:12,,1321844697,7/13/2014 11:45:50,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,48,14,,,55,22,ITCHING,PRURITUS,anal and perianal ITCHING.,30-35-39-48,14-23-27-30,PRURITUS ani is anal,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805281,7/13/2014 11:46:47,,1321844852,7/13/2014 11:46:33,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,48,14,,,55,22,ITCHING,PRURITUS,ITCHING.,48,14,PRURITUS,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805281,7/13/2014 11:55:40,,1321848107,7/13/2014 11:55:21,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,48,14,,,55,22,ITCHING,PRURITUS,ITCHING.,48,0-9-14,PRURITUS ANI PRURITUS,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805281,7/13/2014 11:57:55,,1321848972,7/13/2014 11:57:28,vivatic,1.0,25451531,GBR,"","",83.67.28.193,48,14,,,55,22,ITCHING,PRURITUS,anal and perianal ITCHING.,30-35-39-48,0-9-14-23,PRURITUS ANI PRURITUS ani,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805281,7/13/2014 12:02:42,,1321850858,7/13/2014 12:02:20,instagc,1.0,13763729,USA,"","",75.182.89.225,48,14,,,55,22,ITCHING,PRURITUS,ITCHING.,48,14-23,PRURITUS ani,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805281,7/13/2014 12:03:47,,1321851225,7/13/2014 12:03:35,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,48,14,,,55,22,ITCHING,PRURITUS,anal and perianal ITCHING.,30-35-39-48,0-9-14-23,PRURITUS ANI PRURITUS ani,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805281,7/13/2014 12:08:47,,1321852872,7/13/2014 12:08:17,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,48,14,,,55,22,ITCHING,PRURITUS,anal and perianal ITCHING.,30-35-39-48,0-9-14-23,PRURITUS ANI PRURITUS ani,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805281,7/13/2014 12:09:34,,1321853223,7/13/2014 12:09:09,neodev,1.0,18517457,GBR,"","",86.29.147.112,48,14,,,55,22,ITCHING,PRURITUS,perianal ITCHING.,39-48,14-23,PRURITUS ani,PRURITUS ANI  Pruritus ani is anal and perianal itching.,48,14,48,14,55,22,1,RO-has_definitional_manifestation,904870,PRURITUS ANI  Pruritus ani is anal and perianal itching,itching,Pruritus
502805282,7/13/2014 11:31:03,,1321838659,7/13/2014 11:30:57,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,73,107,,,79,116,LIVERS,CIRRHOSIS,and autoimmune etiology LIVERS cases) with without,49-53-64-73-84-91-99,91-96-99-107-118-122-132-84,"cases) with or without CIRRHOSIS, the incidence of","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805282,7/13/2014 11:47:46,,1321845170,7/13/2014 11:47:28,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,73,107,,,79,116,LIVERS,CIRRHOSIS,LIVERS,73,107,"CIRRHOSIS,","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805282,7/13/2014 11:52:36,,1321846988,7/13/2014 11:52:05,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,73,107,,,79,116,LIVERS,CIRRHOSIS,autoimmune etiology LIVERS,53-64-73,107,"CIRRHOSIS,","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805282,7/13/2014 12:00:08,,1321849888,7/13/2014 11:59:52,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,73,107,,,79,116,LIVERS,CIRRHOSIS,LIVERS,73,107,"CIRRHOSIS,","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805282,7/13/2014 12:01:49,,1321850537,7/13/2014 12:01:23,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,73,107,,,79,116,LIVERS,CIRRHOSIS,autoimmune etiology LIVERS,53-64-73,107,"CIRRHOSIS,","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805282,7/13/2014 12:04:31,,1321851439,7/13/2014 12:04:18,instagc,1.0,13763729,USA,"","",75.182.89.225,73,107,,,79,116,LIVERS,CIRRHOSIS,LIVERS,73,107,"CIRRHOSIS,","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805282,7/13/2014 12:04:49,,1321851546,7/13/2014 12:03:17,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,73,107,,,79,116,LIVERS,CIRRHOSIS,LIVERS,73,107,"CIRRHOSIS,","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805282,7/13/2014 12:08:30,,1321852788,7/13/2014 12:08:06,neodev,1.0,18517457,GBR,"","",86.29.147.112,73,107,,,79,116,LIVERS,CIRRHOSIS,and LIVERS,49-73,107,"CIRRHOSIS,","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805282,7/13/2014 12:09:05,,1321853012,7/13/2014 12:08:48,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,73,107,,,79,116,LIVERS,CIRRHOSIS,autoimmune etiology LIVERS,53-64-73,107,"CIRRHOSIS,","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805282,7/13/2014 12:09:34,,1321853222,7/13/2014 12:09:23,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,73,107,,,79,116,LIVERS,CIRRHOSIS,LIVERS,73,107,"CIRRHOSIS,","In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively.",73,107,73,107,79,116,1,RO-disease_has_primary_anatomic_site,902370,"In chronic active hepatitis of viral (132 cases) and autoimmune etiology livers (20 cases) with or without cirrhosis, the incidence of membranous expression of Lewis Y in clustered hepatocytes of viral and autoimmune etiology livers was 21 and 0% of mild chronic active hepatitis; 69 and 25% of moderate degree; 85 and 50% of severe degree; and 87 and 100% of cirrhosis, respectively",livers,cirrhosis
502805283,7/13/2014 11:29:40,,1321838048,7/13/2014 11:29:34,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,with assessed grades of DYSPLASIA in 32 colorectal,110-119-126-129-139-142-145-105,129-139-142-145-156-168-126,of dysplasia in 32 COLORECTAL ADENOMATOUS POLYPS.,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805283,7/13/2014 11:41:06,,1321842557,7/13/2014 11:40:49,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,DYSPLASIA,129,145-156-168,COLORECTAL ADENOMATOUS POLYPS.,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805283,7/13/2014 11:51:42,,1321846574,7/13/2014 11:51:38,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,assessed grades of DYSPLASIA in 32 colorectal,110-119-126-129-139-142-145,129-139-142-145-156-168,dysplasia in 32 COLORECTAL ADENOMATOUS POLYPS.,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805283,7/13/2014 11:55:27,,1321848006,7/13/2014 11:55:07,vivatic,1.0,25451531,GBR,"","",83.67.28.193,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,DYSPLASIA,129,145-156-168,COLORECTAL ADENOMATOUS POLYPS.,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805283,7/13/2014 11:58:08,,1321849074,7/13/2014 11:57:52,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,DYSPLASIA,129,36-145-156-168,"dysplasia, COLORECTAL ADENOMATOUS POLYPS.","In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805283,7/13/2014 12:02:05,,1321850676,7/13/2014 12:01:50,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,assessed grades of DYSPLASIA,110-119-126-129,145-156-168,COLORECTAL ADENOMATOUS POLYPS.,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805283,7/13/2014 12:03:26,,1321851118,7/13/2014 12:03:08,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,DYSPLASIA,129,145-156-168,COLORECTAL ADENOMATOUS POLYPS.,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805283,7/13/2014 12:05:21,,1321851744,7/13/2014 12:05:04,neodev,1.0,18517457,GBR,"","",86.29.147.112,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,DYSPLASIA,129,145-156-168,COLORECTAL ADENOMATOUS POLYPS.,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805283,7/13/2014 12:07:41,,1321852547,7/13/2014 12:06:54,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,DYSPLASIA,129,145-156-168,COLORECTAL ADENOMATOUS POLYPS.,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805283,7/13/2014 12:08:48,,1321852885,7/13/2014 12:08:12,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,129,145,,,138,174,DYSPLASIA,COLORECTAL ADENOMATOUS POLYPS,DYSPLASIA,129,145-156-168,COLORECTAL ADENOMATOUS POLYPS.,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps.",129,145 156 168,129,145,138,174,1,RO-disease_has_finding,901557,"In order to objectify the degree of dysplasia, results of nuclear and cellular morphometry were compared with assessed grades of dysplasia in 32 colorectal adenomatous polyps",dysplasia,colorectal adenomatous polyps
502805284,7/13/2014 11:38:10,,1321841331,7/13/2014 11:37:42,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS diseases,106-113-141,134-141-150-158,ATOPIC diseases through dietary,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805284,7/13/2014 11:40:04,,1321842098,7/13/2014 11:39:50,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS and other atopic diseases,106-113-124-128-134-141,113-124-128-134-141,dermatitis and other ATOPIC diseases,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805284,7/13/2014 11:42:01,,1321842992,7/13/2014 11:41:54,clixsense,1.0,24763049,GBR,"","",86.133.47.213,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,the prevention of ATOPIC DERMATITIS and other atopic,88-92-103-106-113-124-128-134,113-124-128-134-141-150-158,dermatitis and other ATOPIC diseases through dietary,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805284,7/13/2014 11:54:33,,1321847715,7/13/2014 11:54:16,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS,106-113,134,ATOPIC,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805284,7/13/2014 11:57:50,,1321848951,7/13/2014 11:57:33,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS,106-113,113-134,dermatitis ATOPIC,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805284,7/13/2014 12:01:28,,1321850430,7/13/2014 12:01:02,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS,106-113,113-124-128-134-141,dermatitis and other ATOPIC diseases,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805284,7/13/2014 12:02:04,,1321850669,7/13/2014 12:01:47,instagc,1.0,13763729,USA,"","",75.182.89.225,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS,106-113,134-141,ATOPIC diseases,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805284,7/13/2014 12:02:07,,1321850704,7/13/2014 12:01:39,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS,106-113,134-141,ATOPIC diseases,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805284,7/13/2014 12:05:46,,1321851864,7/13/2014 12:05:17,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS,106-113,134-141,ATOPIC diseases,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805284,7/13/2014 12:10:12,,1321853452,7/13/2014 12:09:55,neodev,1.0,18517457,GBR,"","",86.29.147.112,106,134,,,123,140,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS,106-113,113-134-141,dermatitis ATOPIC diseases,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22.,106 113,134,106,134,123,140,-1,RO-cause_of,900100,This comprehensive and far-reaching review touches on many of the questions relating to the prevention of atopic dermatitis and other atopic diseases through dietary intervention ( 22,atopic dermatitis,atopic
502805285,7/13/2014 11:30:43,,1321838529,7/13/2014 11:30:36,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,84,16,,,89,28,BRAIN,BRAIN LESION,of measures of BRAIN chambers and the rest,69-72-81-84-90-99-103-107,0-6-13-16-22-30-37-46-107,"Total volume of BRAIN LESION, corpus callosum diameter, rest","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805285,7/13/2014 11:37:21,,1321841061,7/13/2014 11:37:07,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,84,16,,,89,28,BRAIN,BRAIN LESION,BRAIN,84,16-22,"BRAIN LESION,","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805285,7/13/2014 11:44:37,,1321843991,7/13/2014 11:44:20,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,84,16,,,89,28,BRAIN,BRAIN LESION,BRAIN,84,16-22,"BRAIN LESION,","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805285,7/13/2014 11:51:48,,1321846595,7/13/2014 11:51:21,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,84,16,,,89,28,BRAIN,BRAIN LESION,BRAIN chambers,84-90,16-22,"BRAIN LESION,","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805285,7/13/2014 11:54:42,,1321847778,7/13/2014 11:53:54,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,84,16,,,89,28,BRAIN,BRAIN LESION,BRAIN chambers,84-90,16-22,"BRAIN LESION,","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805285,7/13/2014 11:56:26,,1321848449,7/13/2014 11:56:04,vivatic,1.0,25451531,GBR,"","",83.67.28.193,84,16,,,89,28,BRAIN,BRAIN LESION,BRAIN chambers,84-90,16-22,"BRAIN LESION,","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805285,7/13/2014 11:57:25,,1321848765,7/13/2014 11:57:14,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,84,16,,,89,28,BRAIN,BRAIN LESION,BRAIN chambers,84-90,16-22,"BRAIN LESION,","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805285,7/13/2014 12:06:14,,1321852076,7/13/2014 12:05:58,neodev,1.0,18517457,GBR,"","",86.29.147.112,84,16,,,89,28,BRAIN,BRAIN LESION,BRAIN chambers,84-90,16-22,"BRAIN LESION,","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805285,7/13/2014 12:09:48,,1321853300,7/13/2014 12:09:35,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,84,16,,,89,28,BRAIN,BRAIN LESION,BRAIN,84,16-22,"BRAIN LESION,","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805285,7/13/2014 12:14:01,,1321854674,7/13/2014 12:13:33,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,84,16,,,89,28,BRAIN,BRAIN LESION,BRAIN,84,16-22,"BRAIN LESION,","Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis.",84,16 22,84,16,89,28,1,RO-has_finding_site,905397,"Total volume of brain lesion, corpus callosum diameter, and relation of measures of brain chambers and the rest of the brain, are best indices of cognitive dysfunction in multiple sclerosis",brain,brain lesion
502805286,7/13/2014 11:31:19,,1321838743,7/13/2014 11:31:14,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,treatment of patients with HEMOPHILIA A. We successfully,88-91-100-105-116-119-122-78,16-19-30-33-40-45-48-50-116,of antibodies to FACTOR VIII is a serious A.,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805286,7/13/2014 11:40:00,,1321842074,7/13/2014 11:39:42,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,HEMOPHILIA A.,105-116,33-40,FACTOR VIII,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805286,7/13/2014 11:46:03,,1321844650,7/13/2014 11:45:43,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,HEMOPHILIA A.,105-116,19-33-40,antibodies FACTOR VIII,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805286,7/13/2014 11:51:16,,1321846422,7/13/2014 11:50:49,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,HEMOPHILIA,105,19-33-40,antibodies FACTOR VIII,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805286,7/13/2014 11:53:20,,1321847232,7/13/2014 11:51:33,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,HEMOPHILIA,105,19-30-33-40,antibodies to FACTOR VIII,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805286,7/13/2014 11:54:33,,1321847716,7/13/2014 11:54:12,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,HEMOPHILIA A.,105-116,33-40,FACTOR VIII,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805286,7/13/2014 11:55:06,,1321847871,7/13/2014 11:54:37,vivatic,1.0,25451531,GBR,"","",83.67.28.193,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,HEMOPHILIA A.,105-116,33-40,FACTOR VIII,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805286,7/13/2014 11:57:39,,1321848860,7/13/2014 11:57:26,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,HEMOPHILIA A.,105-116,33-40,FACTOR VIII,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805286,7/13/2014 11:58:12,,1321849080,7/13/2014 11:57:51,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,HEMOPHILIA A.,105-116,33-40,FACTOR VIII,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805286,7/13/2014 11:58:25,,1321849176,7/13/2014 11:57:39,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,105,33,,,115,44,HEMOPHILIA,FACTOR VIII,HEMOPHILIA A.,105-116,33-40-19,antibodies FACTOR VIII,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII.",105,33 40,105,33,115,44,1,RO-may_treat,908360,"The development of antibodies to factor VIII is a serious complication of the treatment of patients with hemophilia A. We successfully induced immune tolerance in patients with such antibodies with a new treatment protocol, which combined factor VIII, cyclophosphamide, and high-dose intravenous IgG, followed by regular prophylactic treatment with factor VIII",hemophilia,factor VIII
502805287,7/13/2014 11:41:31,,1321842729,7/13/2014 11:41:02,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,butyrylcholinesterase (BCHE) of mucosal cells,15-37-44-47-55,15-37-44-47-55,BUTYRYLCHOLINESTERASE (BChE) of mucosal cells,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805287,7/13/2014 11:43:06,,1321843453,7/13/2014 11:42:47,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,of butyrylcholinesterase (BCHE) of mucosal cells,12-15-37-44-47-55,4-7-12-15-44-47,G2 form of BUTYRYLCHOLINESTERASE of mucosal,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805287,7/13/2014 11:44:44,,1321844039,7/13/2014 11:44:36,clixsense,1.0,24763049,GBR,"","",86.133.47.213,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,of butyrylcholinesterase (BCHE) of mucosal cells,12-15-37-44-47-55,4-7-12-15-44-47,G2 form of BUTYRYLCHOLINESTERASE of mucosal,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805287,7/13/2014 11:47:06,,1321844932,7/13/2014 11:46:34,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,butyrylcholinesterase (BCHE) of mucosal cells,15-37-44-47-55,4-7-12-15-44-47,G2 form of BUTYRYLCHOLINESTERASE of mucosal,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805287,7/13/2014 11:48:18,,1321845394,7/13/2014 11:47:47,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,(BCHE),37,15,BUTYRYLCHOLINESTERASE,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805287,7/13/2014 11:59:18,,1321849576,7/13/2014 11:58:39,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,butyrylcholinesterase (BCHE),15-37,15-37,BUTYRYLCHOLINESTERASE (BChE),"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805287,7/13/2014 12:00:19,,1321849969,7/13/2014 11:59:54,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,butyrylcholinesterase (BCHE),15-37,15,BUTYRYLCHOLINESTERASE,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805287,7/13/2014 12:01:33,,1321850462,7/13/2014 12:00:39,neodev,1.0,18517457,GBR,"","",86.29.147.112,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,(BCHE),37,15,BUTYRYLCHOLINESTERASE,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805287,7/13/2014 12:03:34,,1321851172,7/13/2014 12:03:04,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,butyrylcholinesterase (BCHE) of mucosal cells,15-37-44-47-55,15,BUTYRYLCHOLINESTERASE,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805287,7/13/2014 12:04:52,,1321851589,7/13/2014 12:04:15,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,38,15,,,42,36,BCHE,BUTYRYLCHOLINESTERASE,butyrylcholinesterase (BCHE),15-37,15-37,BUTYRYLCHOLINESTERASE (BChE),"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase.",,15,38,15,42,36,-1,RO-has_manifestation,906286,"The G2 form of butyrylcholinesterase (BChE) of mucosal cells of rat intestine is a rare amphiphilic species, which is related to class II of acetylcholinesterase",BChE,butyrylcholinesterase
502805288,7/13/2014 11:41:08,,1321842565,7/13/2014 11:40:45,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,"palpitations, flushing and HYPERTENSION suggestive of pheochromocytoma.",36-50-59-63-76-87-90,63-76-87-90,hypertension suggestive of PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805288,7/13/2014 11:45:11,,1321844264,7/13/2014 11:44:55,clixsense,1.0,24763049,GBR,"","",86.133.47.213,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,"palpitations, flushing and HYPERTENSION suggestive of pheochromocytoma.",36-50-59-63-76-87-90,63-76-87-90,hypertension suggestive of PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805288,7/13/2014 11:52:15,,1321846846,7/13/2014 11:52:13,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,"palpitations, flushing and HYPERTENSION suggestive of pheochromocytoma.",36-50-59-63-76-87-90,63-76-87-90,hypertension suggestive of PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805288,7/13/2014 12:00:33,,1321850093,7/13/2014 12:00:12,vivatic,1.0,25451531,GBR,"","",83.67.28.193,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,63,90,PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805288,7/13/2014 12:01:21,,1321850375,7/13/2014 12:00:49,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,63,90,PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805288,7/13/2014 12:02:48,,1321850894,7/13/2014 12:02:37,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,63,90,PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805288,7/13/2014 12:03:15,,1321851057,7/13/2014 12:02:27,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,63,90,PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805288,7/13/2014 12:04:24,,1321851389,7/13/2014 12:04:08,neodev,1.0,18517457,GBR,"","",86.29.147.112,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,63,90,PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805288,7/13/2014 12:09:11,,1321853043,7/13/2014 12:08:53,instagc,1.0,13763729,USA,"","",75.182.89.225,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,63,90,PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805288,7/13/2014 12:12:24,,1321854052,7/13/2014 12:12:06,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,63,90,,,75,106,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,63,90,PHEOCHROMOCYTOMA.,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma.",63,90,63,90,75,106,1,RO-disease_may_have_finding,902644,"On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma",hypertension,pheochromocytoma
502805289,7/13/2014 11:27:19,,1321837176,7/13/2014 11:27:11,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,"toxoid late 1950s, epidemic DIPHTHERIA has reemerged in",139-144-151-160-171-175-185-125,87-97-109-114-125-132-135-139-84,of childhood vaccination with DIPHTHERIA TOXOID in the late,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805289,7/13/2014 11:29:13,,1321837830,7/13/2014 11:28:40,clixsense,1.0,24763049,GBR,"","",86.133.47.213,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,"late 1950s, epidemic DIPHTHERIA has reemerged in",139-144-151-160-171-175-185,87-97-109-114-125-132-135-139,childhood vaccination with DIPHTHERIA TOXOID in the late,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805289,7/13/2014 11:36:34,,1321840816,7/13/2014 11:36:17,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,DIPHTHERIA,160,87-97-109-114-125,childhood vaccination with DIPHTHERIA TOXOID,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805289,7/13/2014 11:49:13,,1321845680,7/13/2014 11:48:55,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,DIPHTHERIA,160,114-125,DIPHTHERIA TOXOID,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805289,7/13/2014 11:53:25,,1321847241,7/13/2014 11:52:58,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,epidemic DIPHTHERIA,151-160,114-125,DIPHTHERIA TOXOID,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805289,7/13/2014 11:56:11,,1321848341,7/13/2014 11:55:58,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,DIPHTHERIA,160,114-125,DIPHTHERIA TOXOID,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805289,7/13/2014 11:56:21,,1321848417,7/13/2014 11:56:03,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,DIPHTHERIA,160,114-125,DIPHTHERIA TOXOID,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805289,7/13/2014 12:01:22,,1321850374,7/13/2014 12:00:56,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,epidemic DIPHTHERIA,151-160,114-125,DIPHTHERIA TOXOID,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805289,7/13/2014 12:03:03,,1321850979,7/13/2014 12:02:44,neodev,1.0,18517457,GBR,"","",86.29.147.112,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,DIPHTHERIA,160,114-125,DIPHTHERIA TOXOID,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805289,7/13/2014 12:03:23,,1321851110,7/13/2014 12:03:09,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,160,114,,,170,131,DIPHTHERIA,DIPHTHERIA TOXOID,epidemic DIPHTHERIA,151-160,114-125,DIPHTHERIA TOXOID,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2.",160,114 125,160,114,170,131,1,RO-may_prevent,907064,"Although diphtheria was controlled for approximately 30 years after the institution of childhood vaccination with diphtheria toxoid in the late 1950s, epidemic diphtheria has reemerged in the New Independent States (NIS) of the former Soviet Union (1,2) (Figures 1 and 2",diphtheria,diphtheria toxoid
502805290,7/13/2014 11:26:54,,1321837057,7/13/2014 11:26:48,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,the developing and adult NERVOUS SYSTEM and their potential,81-92-96-102-110-117-121-127-77,153-157-166-169-182-96,adult the etiology of NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805290,7/13/2014 11:34:16,,1321839910,7/13/2014 11:33:59,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,NERVOUS SYSTEM,102-110,169-182,NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805290,7/13/2014 11:51:07,,1321846355,7/13/2014 11:49:02,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,developing and adult NERVOUS SYSTEM and their potential,81-92-96-102-110-117-121-127,153-157-166-169-182,the etiology of NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805290,7/13/2014 11:52:38,,1321846996,7/13/2014 11:52:20,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,NERVOUS SYSTEM,102-110,169-182,NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805290,7/13/2014 11:54:16,,1321847593,7/13/2014 11:53:50,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,NERVOUS SYSTEM,102-110,169-182,NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805290,7/13/2014 11:58:39,,1321849281,7/13/2014 11:58:21,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,NERVOUS SYSTEM,102-110,169-182,NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805290,7/13/2014 12:03:08,,1321850995,7/13/2014 12:02:52,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,developing and adult NERVOUS SYSTEM,81-92-96-102-110,169-182,NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805290,7/13/2014 12:09:22,,1321853142,7/13/2014 12:09:09,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,NERVOUS SYSTEM,102-110,169-182,NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805290,7/13/2014 12:09:52,,1321853343,7/13/2014 12:09:34,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,NERVOUS SYSTEM,102-110,169-182,NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805290,7/13/2014 12:10:45,,1321853587,7/13/2014 12:09:49,gifthulk,1.0,25566511,USA,"","",24.164.11.173,102,169,,,116,190,NERVOUS SYSTEM,NEUROLOGICAL DISEASES,adult NERVOUS SYSTEM,102-110-96,169-182,NEUROLOGICAL DISEASES.,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases.,102 110,169 182,102,169,116,190,1,RO-has_finding_site,905142,This review summarizes the current knowledge of the function of microRNAs in the developing and adult nervous system and their potential contribution to the etiology of neurological diseases,nervous system,neurological diseases
502805291,7/13/2014 11:33:20,,1321839581,7/13/2014 11:33:02,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,DIABETIC KETOACIDOSIS,142-151,98-107,DIABETES mellitus,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805291,7/13/2014 11:35:03,,1321840249,7/13/2014 11:34:26,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,PIs; DIABETIC KETOACIDOSIS,142-151-137,98-107,DIABETES mellitus,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805291,7/13/2014 11:38:36,,1321841570,7/13/2014 11:38:19,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,DIABETIC KETOACIDOSIS,142-151,86-98-107,preexisting DIABETES mellitus,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805291,7/13/2014 11:51:57,,1321846712,7/13/2014 11:51:38,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,DIABETIC KETOACIDOSIS,142-151,98-107,DIABETES mellitus,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805291,7/13/2014 11:52:14,,1321846845,7/13/2014 11:51:55,vivatic,1.0,25451531,GBR,"","",83.67.28.193,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,DIABETIC KETOACIDOSIS,142-151,98-107,DIABETES mellitus,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805291,7/13/2014 11:52:38,,1321846989,7/13/2014 11:52:22,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,DIABETIC KETOACIDOSIS,142-151,86-98-107,preexisting DIABETES mellitus,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805291,7/13/2014 11:53:02,,1321847142,7/13/2014 11:52:59,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,use of PIs; DIABETIC KETOACIDOSIS has occurred.,130-134-137-142-151-164-168,70-83-86-98-107-116-125,exacerbation of preexisting DIABETES mellitus reported with,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805291,7/13/2014 11:54:48,,1321847794,7/13/2014 11:54:19,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,"Hyperglycemia, diabetes mellitus, DIABETIC KETOACIDOSIS",23-48-57-142-151,98-107-151-23,"Hyperglycemia, DIABETES mellitus ketoacidosis","Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805291,7/13/2014 12:02:22,,1321850796,7/13/2014 12:01:59,neodev,1.0,18517457,GBR,"","",86.29.147.112,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,DIABETIC KETOACIDOSIS,142-151,70-98-107,exacerbation DIABETES mellitus,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805291,7/13/2014 12:03:03,,1321850978,7/13/2014 12:02:49,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,142,98,,,163,106,DIABETIC KETOACIDOSIS,DIABETES,DIABETIC KETOACIDOSIS,142-151,86-98-107,preexisting DIABETES mellitus,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred.",142 151,98,142,98,163,106,-1,RO-cause_of,900112,"Hyperglycemic Effects  Hyperglycemia, new-onset diabetes mellitus, or exacerbation of preexisting diabetes mellitus reported with use of PIs; diabetic ketoacidosis has occurred",diabetic ketoacidosis,diabetes
502805292,7/13/2014 11:36:44,,1321840875,7/13/2014 11:36:30,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,myelocytic LEUKEMIA,44-55,108-117,CYTOSINE ARABINOSIDE,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805292,7/13/2014 11:38:01,,1321841254,7/13/2014 11:37:42,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,acute myelocytic LEUKEMIA,38-44-55,85-95-103-108-117-129-133,induction therapy with CYTOSINE ARABINOSIDE and idarubicin,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805292,7/13/2014 11:38:40,,1321841603,7/13/2014 11:38:11,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,acute myelocytic LEUKEMIA,38-44-55,108-117,CYTOSINE ARABINOSIDE,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805292,7/13/2014 11:43:43,,1321843705,7/13/2014 11:43:34,clixsense,1.0,24763049,GBR,"","",86.133.47.213,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,with acute myelocytic LEUKEMIA failed to respond,33-38-44-55-64-71-74,85-95-103-108-117-129-133-144,induction therapy with CYTOSINE ARABINOSIDE and idarubicin and,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805292,7/13/2014 11:45:34,,1321844388,7/13/2014 11:45:16,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,LEUKEMIA,55,108-117,CYTOSINE ARABINOSIDE,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805292,7/13/2014 11:51:14,,1321846391,7/13/2014 11:51:08,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,with acute myelocytic LEUKEMIA failed to respond,33-38-44-55-64-71-74,85-95-103-108-117-129-133-144,induction therapy with CYTOSINE ARABINOSIDE and idarubicin and,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805292,7/13/2014 11:56:52,,1321848615,7/13/2014 11:56:42,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,acute myelocytic LEUKEMIA,38-44-55,108-117-129-133,CYTOSINE ARABINOSIDE and idarubicin,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805292,7/13/2014 12:00:06,,1321849885,7/13/2014 11:59:20,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,acute myelocytic LEUKEMIA,38-44-55,108-117,CYTOSINE ARABINOSIDE,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805292,7/13/2014 12:01:41,,1321850499,7/13/2014 12:01:11,vivatic,1.0,25451531,GBR,"","",83.67.28.193,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,acute myelocytic LEUKEMIA,38-44-55,108-117,CYTOSINE ARABINOSIDE,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805292,7/13/2014 12:03:32,,1321851170,7/13/2014 12:03:14,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,55,108,,,63,128,LEUKEMIA,CYTOSINE ARABINOSIDE,acute myelocytic LEUKEMIA,38-44-55,108-117-129-133,CYTOSINE ARABINOSIDE and idarubicin,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin.",55,108 117,55,108,63,128,1,RO-may_treat,907921,"CASE SCENARIO  A 30-year-old man with acute myelocytic leukemia failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, cytosine arabinoside, G-CSF, and idarubicin",leukemia,cytosine arabinoside
502805293,7/13/2014 11:30:28,,1321838425,7/13/2014 11:30:22,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,189,131,,,196,139,SEIZURE,EPILEPSY,those in whom SEIZURE control was attained medication,175-181-184-189-197-205-209-272,110-119-124-131-140-143-153-100,groups children with benign EPILEPSY of childhood with,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805293,7/13/2014 11:33:00,,1321839404,7/13/2014 11:32:38,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,189,131,,,196,139,SEIZURE,EPILEPSY,SEIZURE,189,124-131-140-143,benign EPILEPSY of childhood,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805293,7/13/2014 11:35:28,,1321840371,7/13/2014 11:35:04,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,189,131,,,196,139,SEIZURE,EPILEPSY,SEIZURE,189,124-131,benign EPILEPSY,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805293,7/13/2014 11:42:50,,1321843352,7/13/2014 11:42:45,clixsense,1.0,24763049,GBR,"","",86.133.47.213,189,131,,,196,139,SEIZURE,EPILEPSY,those in whom SEIZURE control was attained,175-181-184-189-197-205-209,110-119-124-131-140-143-153,children with benign EPILEPSY of childhood with,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805293,7/13/2014 11:51:17,,1321846423,7/13/2014 11:50:58,vivatic,1.0,25451531,GBR,"","",83.67.28.193,189,131,,,196,139,SEIZURE,EPILEPSY,SEIZURE,189,124-131,benign EPILEPSY,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805293,7/13/2014 11:52:50,,1321847091,7/13/2014 11:52:48,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,189,131,,,196,139,SEIZURE,EPILEPSY,those in whom SEIZURE control was attained,175-181-184-189-197-205-209,110-119-124-131-140-143-153,children with benign EPILEPSY of childhood with,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805293,7/13/2014 11:52:57,,1321847107,7/13/2014 11:52:06,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,189,131,,,196,139,SEIZURE,EPILEPSY,SEIZURE,189,124-131,benign EPILEPSY,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805293,7/13/2014 11:55:38,,1321848091,7/13/2014 11:54:43,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,189,131,,,196,139,SEIZURE,EPILEPSY,SEIZURE control,189-197,124-131,benign EPILEPSY,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805293,7/13/2014 11:57:13,,1321848741,7/13/2014 11:56:56,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,189,131,,,196,139,SEIZURE,EPILEPSY,SEIZURE control,189-197,124-131,benign EPILEPSY,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805293,7/13/2014 11:57:32,,1321848811,7/13/2014 11:57:10,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,189,131,,,196,139,SEIZURE,EPILEPSY,epilepsy SEIZURE,189-131,124-131,benign EPILEPSY,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2.,189,131,189,131,196,139,-1,RO-has_definitional_manifestation,904580,The objective of this study was to compare the clinical and electroencephalographic features of two groups of children with benign epilepsy of childhood with rolandic spikes: those in whom seizure control was attained either without the use of medication or with a single medication (group 1) and those requiring two medications for seizure control (group 2,seizure,epilepsy
502805294,7/13/2014 11:51:27,,1321846457,7/13/2014 11:51:24,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,57,101,,,66,109,PREGNANCY,WARFARIN,"treatment with warfarin, PREGNANCY should be avoided",32-42-47-57-67-74-77,85-88-97-101-110-117-120,"or planned, and WARFARIN should be discontinued","When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805294,7/13/2014 11:52:05,,1321846772,7/13/2014 11:51:39,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,57,101,,,66,109,PREGNANCY,WARFARIN,PREGNANCY,57,101,WARFARIN,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805294,7/13/2014 11:52:34,,1321846979,7/13/2014 11:52:16,vivatic,1.0,25451531,GBR,"","",83.67.28.193,57,101,,,66,109,PREGNANCY,WARFARIN,PREGNANCY,57,101,WARFARIN,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805294,7/13/2014 11:54:52,,1321847798,7/13/2014 11:54:34,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,57,101,,,66,109,PREGNANCY,WARFARIN,PREGNANCY,57,101,WARFARIN,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805294,7/13/2014 12:00:20,,1321849973,7/13/2014 12:00:09,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,57,101,,,66,109,PREGNANCY,WARFARIN,PREGNANCY,57,101,WARFARIN,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805294,7/13/2014 12:00:42,,1321850110,7/13/2014 12:00:08,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,57,101,,,66,109,PREGNANCY,WARFARIN,PREGNANCY,57,101,WARFARIN,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805294,7/13/2014 12:01:38,,1321850484,7/13/2014 12:01:11,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,57,101,,,66,109,PREGNANCY,WARFARIN,PREGNANCY,57,101,WARFARIN,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805294,7/13/2014 12:05:05,,1321851639,7/13/2014 12:04:47,instagc,1.0,13763729,USA,"","",75.182.89.225,57,101,,,66,109,PREGNANCY,WARFARIN,PREGNANCY,57,101,WARFARIN,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805294,7/13/2014 12:05:56,,1321851953,7/13/2014 12:05:42,neodev,1.0,18517457,GBR,"","",86.29.147.112,57,101,,,66,109,PREGNANCY,WARFARIN,PREGNANCY,57,101,WARFARIN,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805294,7/13/2014 12:10:00,,1321853391,7/13/2014 12:09:49,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,57,101,,,66,109,PREGNANCY,WARFARIN,PREGNANCY,57,101,WARFARIN,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation.",57,101,57,101,66,109,1,RO-contraindicated_drug,901070,"When patients receive long-term treatment with warfarin, pregnancy should be avoided or planned, and warfarin should be discontinued before conception or as soon as pregnancy is confirmed and before 6-weeks' gestation",pregnancy,warfarin
502805295,7/13/2014 11:27:09,,1321837135,7/13/2014 11:27:02,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,"apparent, including protein CALORIE MALNUTRITION and various vitamin illnesses",174-184-194-202-210-223-227-235-292,118-124-129-137-149-162-167-174-108,"months years that follow, NUTRITIONAL DEFICIENCIES have become apparent,","Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805295,7/13/2014 11:43:53,,1321843759,7/13/2014 11:43:29,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,protein - CALORIE MALNUTRITION,194-202-210-201,137-149,NUTRITIONAL DEFICIENCIES,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805295,7/13/2014 11:49:00,,1321845638,7/13/2014 11:47:15,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,protein - CALORIE MALNUTRITION,194-202-210-201,137-149,NUTRITIONAL DEFICIENCIES,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805295,7/13/2014 11:51:08,,1321846363,7/13/2014 11:50:39,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,protein CALORIE MALNUTRITION,194-202-210,137-149,NUTRITIONAL DEFICIENCIES,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805295,7/13/2014 12:03:26,,1321851116,7/13/2014 12:03:08,neodev,1.0,18755947,GBR,H2,Accrington,80.47.185.52,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,protein CALORIE MALNUTRITION,194-202-210,137-149,NUTRITIONAL DEFICIENCIES,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805295,7/13/2014 12:03:54,,1321851246,7/13/2014 12:03:33,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,CALORIE MALNUTRITION,202-210,137-149,NUTRITIONAL DEFICIENCIES,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805295,7/13/2014 12:04:47,,1321851527,7/13/2014 12:04:32,instagc,1.0,13763729,USA,"","",75.182.89.225,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,CALORIE MALNUTRITION,202-210,137-149,NUTRITIONAL DEFICIENCIES,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805295,7/13/2014 12:08:16,,1321852755,7/13/2014 12:07:51,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,protein CALORIE MALNUTRITION,194-202-210,137-149,NUTRITIONAL DEFICIENCIES,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805295,7/13/2014 12:11:41,,1321853859,7/13/2014 12:11:00,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,CALORIE MALNUTRITION,202-210,137-149,NUTRITIONAL DEFICIENCIES,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805295,7/13/2014 12:14:26,,1321854781,7/13/2014 12:13:47,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,202,137,,,222,161,CALORIE MALNUTRITION,NUTRITIONAL DEFICIENCIES,protein CALORIE MALNUTRITION and various vitamin and mineral deficiencies,194-202-210-223-227-235-243-247-255,137-149,NUTRITIONAL DEFICIENCIES,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health.",202 210,137 149,202,137,222,161,-1,RO-cause_of,900160,"Unfortunately the nutritional adequacy of the postoperative diet has frequently been overlooked, and in the months to years that follow, nutritional deficiencies have become apparent, including protein-calorie malnutrition and various vitamin and mineral deficiencies contributing to medical illnesses and limiting optimal health",calorie malnutrition,nutritional deficiencies
502805296,7/13/2014 11:43:46,,1321843726,7/13/2014 11:43:26,eup_slw,1,21338859,GBR,K6,Portsmouth,86.6.113.168,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,autoerotic ASPHYXIA.,109-120,28-35,sexual ASPHYXIATION,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805296,7/13/2014 11:51:51,,1321846639,7/13/2014 11:51:48,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,context of autoerotic ASPHYXIA.,98-106-109-120,20-25-28-35-48-51-62,"form of sexual ASPHYXIATION is described, involving","A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805296,7/13/2014 11:54:06,,1321847545,7/13/2014 11:53:50,vivatic,1.0,25451531,GBR,"","",83.67.28.193,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,autoerotic ASPHYXIA.,109-120,28-35,sexual ASPHYXIATION,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805296,7/13/2014 11:56:23,,1321848427,7/13/2014 11:56:09,clixsense,1,27871219,NLD,07,Amsterdam,87.210.207.223,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,autoerotic ASPHYXIA.,109-120,28-35,sexual ASPHYXIATION,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805296,7/13/2014 11:57:24,,1321848763,7/13/2014 11:57:12,tremorgames,1,26860817,NLD,06,Boxmeer,84.29.157.221,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,ASPHYXIA.,120,28-35,sexual ASPHYXIATION,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805296,7/13/2014 12:02:15,,1321850775,7/13/2014 12:01:43,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,autoerotic ASPHYXIA.,109-120,28-35,sexual ASPHYXIATION,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805296,7/13/2014 12:03:35,,1321851180,7/13/2014 12:03:24,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,autoerotic ASPHYXIA.,109-120,28-35,sexual ASPHYXIATION,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805296,7/13/2014 12:06:53,,1321852267,7/13/2014 12:06:15,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,autoerotic ASPHYXIA.,109-120,35,ASPHYXIATION,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805296,7/13/2014 12:07:43,,1321852549,7/13/2014 12:07:29,neodev,1,28269997,GBR,H9,London,151.224.171.48,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,autoerotic ASPHYXIA.,109-120,28-35,sexual ASPHYXIATION,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805296,7/13/2014 12:08:10,,1321852731,7/13/2014 12:07:53,instagc,1.0,13763729,USA,"","",75.182.89.225,120,35,,,128,47,ASPHYXIA,ASPHYXIATION,ASPHYXIA.,120,35,ASPHYXIATION,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia.",120,35,120,35,128,47,-1,RO-cause_of,900348,"A case of a typical form of sexual asphyxiation is described, involving a young man hanging, in a context of autoerotic asphyxia",asphyxia,asphyxiation
502805297,7/13/2014 11:31:39,,1321838851,7/13/2014 11:31:30,clixsense,1.0,24763049,GBR,"","",86.133.47.213,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,could be a MECONIUM dose dependent response,159-165-168-170-179-184-194,67-78-81-85-94-105-115-118-123,"reactivity in the MECONIUM ASPIRATION SYNDROME, in this study","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805297,7/13/2014 11:36:01,,1321840602,7/13/2014 11:35:43,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,MECONIUM,170,85-94-105,"MECONIUM ASPIRATION SYNDROME,","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805297,7/13/2014 11:44:33,,1321843982,7/13/2014 11:43:54,clixsense,1,27969116,NLD,04,Veendam,185.12.216.74,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,MECONIUM dose dependent response of tracheal smooth muscle,170-179-184-194-206-215-222-203,85-94-105,"MECONIUM ASPIRATION SYNDROME,","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805297,7/13/2014 11:52:59,,1321847114,7/13/2014 11:52:39,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,MECONIUM,170,85-94-105,"MECONIUM ASPIRATION SYNDROME,","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805297,7/13/2014 11:53:01,,1321847129,7/13/2014 11:52:27,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,MECONIUM dose dependent response,170-179-184-194,67-78-81-85-94-105,"reactivity in the MECONIUM ASPIRATION SYNDROME,","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805297,7/13/2014 11:55:44,,1321848142,7/13/2014 11:55:21,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,MECONIUM,170,85-94-105,"MECONIUM ASPIRATION SYNDROME,","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805297,7/13/2014 11:58:31,,1321849225,7/13/2014 11:58:09,prodege,1,28022571,GBR,P2,Warrington,82.24.80.237,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,"meconium aspiration syndrome, MECONIUM",85-94-170-105,85-94-105,"MECONIUM ASPIRATION SYNDROME,","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805297,7/13/2014 11:58:43,,1321849304,7/13/2014 11:58:17,vivatic,1.0,25451531,GBR,"","",83.67.28.193,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,MECONIUM dose dependent response,170-179-184-194,85-94-105,"MECONIUM ASPIRATION SYNDROME,","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805297,7/13/2014 11:58:55,,1321849362,7/13/2014 11:58:40,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,MECONIUM dose dependent response,170-179-184-194,85-94-105,"MECONIUM ASPIRATION SYNDROME,","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805297,7/13/2014 12:01:51,,1321850562,7/13/2014 12:01:29,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,170,85,,,178,113,MECONIUM,MECONIUM ASPIRATION SYNDROME,MECONIUM dose dependent response,170-179-184-194,85-94-105,"MECONIUM ASPIRATION SYNDROME,","To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.",170,85 94 105,170,85,178,113,1,RO-has_causative_agent,903672,"To better understand the mechanisms contributing to altered airway reactivity in the meconium aspiration syndrome, in this study we investigated whether there could be a meconium dose-dependent response of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro",meconium,meconium aspiration syndrome
502805298,7/13/2014 11:30:08,,1321838231,7/13/2014 11:30:01,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,172,220,,,176,232,BONE,OSTEOPOROSIS,polymorphism may affect BONE mineral metabolism and complication,148-161-165-172-177-185-196-238,204-212-217-220-233-236-238-262,predict risk of OSTEOPOROSIS as a complication disease,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805298,7/13/2014 11:47:34,,1321845094,7/13/2014 11:47:12,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,172,220,,,176,232,BONE,OSTEOPOROSIS,BONE mineral metabolism,172-177-185,220,OSTEOPOROSIS,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805298,7/13/2014 11:48:53,,1321845607,7/13/2014 11:48:33,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,172,220,,,176,232,BONE,OSTEOPOROSIS,BONE,172,220,OSTEOPOROSIS,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805298,7/13/2014 11:52:27,,1321846931,7/13/2014 11:52:24,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,172,220,,,176,232,BONE,OSTEOPOROSIS,polymorphism may affect BONE mineral metabolism and,148-161-165-172-177-185-196,204-212-217-220-233-236-238,predict risk of OSTEOPOROSIS as a complication,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805298,7/13/2014 11:53:34,,1321847325,7/13/2014 11:53:02,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,172,220,,,176,232,BONE,OSTEOPOROSIS,BONE mineral metabolism,172-177-185,212-217-220,risk of OSTEOPOROSIS,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805298,7/13/2014 11:56:24,,1321848429,7/13/2014 11:56:07,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,172,220,,,176,232,BONE,OSTEOPOROSIS,BONE mineral metabolism,172-177-185,220,OSTEOPOROSIS,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805298,7/13/2014 11:56:26,,1321848458,7/13/2014 11:56:11,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,172,220,,,176,232,BONE,OSTEOPOROSIS,BONE mineral metabolism,172-177-185,220,OSTEOPOROSIS,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805298,7/13/2014 11:59:21,,1321849590,7/13/2014 11:59:09,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,172,220,,,176,232,BONE,OSTEOPOROSIS,BONE mineral metabolism,172-177-185,220,OSTEOPOROSIS,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805298,7/13/2014 12:02:34,,1321850845,7/13/2014 12:01:38,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,172,220,,,176,232,BONE,OSTEOPOROSIS,BONE,172,220,OSTEOPOROSIS,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805298,7/13/2014 12:04:34,,1321851451,7/13/2014 12:04:08,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,172,220,,,176,232,BONE,OSTEOPOROSIS,BONE,172,220,OSTEOPOROSIS,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission.",172,220,172,220,176,232,1,RO-disease_has_primary_anatomic_site,902487,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR-FokI polymorphism may affect bone mineral metabolism and can predict risk of osteoporosis as a complication of Graves' disease in patients in remission",bone,osteoporosis
502805299,7/13/2014 11:32:46,,1321839256,7/13/2014 11:32:40,clixsense,1.0,24763049,GBR,"","",86.133.47.213,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,is an autoimmune LIVER disease characterized by,59-62-65-76-82-90-104,8-16-26-33-41-49-59-62-65,BILIARY CIRRHOSIS (PBC) PRIMARY BILIARY CIRRHOSIS is an autoimmune,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805299,7/13/2014 11:35:06,,1321840284,7/13/2014 11:34:50,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,autoimmune LIVER disease,65-76-82,8-16-26-33-41-49,BILIARY CIRRHOSIS (PBC) PRIMARY BILIARY CIRRHOSIS,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805299,7/13/2014 11:39:21,,1321841851,7/13/2014 11:39:02,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,LIVER,76,33-41-49,PRIMARY BILIARY CIRRHOSIS,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805299,7/13/2014 11:40:47,,1321842412,7/13/2014 11:40:25,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,LIVER,76,33-41-49,PRIMARY BILIARY CIRRHOSIS,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805299,7/13/2014 11:41:57,,1321842918,7/13/2014 11:41:32,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,autoimmune LIVER disease,65-76-82,8-16-26-33-41-49,BILIARY CIRRHOSIS (PBC) PRIMARY BILIARY CIRRHOSIS,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805299,7/13/2014 12:01:10,,1321850313,7/13/2014 12:00:34,vivatic,1.0,25451531,GBR,"","",83.67.28.193,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,autoimmune LIVER disease,65-76-82,33-41-49,PRIMARY BILIARY CIRRHOSIS,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805299,7/13/2014 12:03:18,,1321851092,7/13/2014 12:03:01,instagc,1.0,13763729,USA,"","",75.182.89.225,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,LIVER disease,76-82,33-41-49,PRIMARY BILIARY CIRRHOSIS,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805299,7/13/2014 12:05:38,,1321851832,7/13/2014 12:05:23,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,autoimmune LIVER disease,65-76-82,8-16-26-33-41-49,BILIARY CIRRHOSIS (PBC) PRIMARY BILIARY CIRRHOSIS,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805299,7/13/2014 12:06:34,,1321852191,7/13/2014 12:05:49,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,autoimmune LIVER disease,65-76-82,33-41-49,PRIMARY BILIARY CIRRHOSIS,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805299,7/13/2014 12:07:43,,1321852557,7/13/2014 12:07:14,neodev,1.0,18517457,GBR,"","",86.29.147.112,76,33,,,81,58,LIVER,PRIMARY BILIARY CIRRHOSIS,is autoimmune LIVER disease,59-65-76-82,26-33-41-49,(PBC) PRIMARY BILIARY CIRRHOSIS,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure.",76,33 41 49,76,33,81,58,1,RO-disease_has_primary_anatomic_site,902166,"PRIMARY BILIARY CIRRHOSIS (PBC)  Primary biliary cirrhosis is an autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis, cirrhosis, and liver failure",liver,Primary biliary cirrhosis
502805300,7/13/2014 11:28:49,,1321837683,7/13/2014 11:28:05,neodev,1,26834562,CAN,ON,Port Dover,24.102.39.105,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS is a,0-9-19-25-46-49,61-67,LUPUS ERYTHEMATOSUS,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805300,7/13/2014 11:30:35,,1321838475,7/13/2014 11:30:30,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS is a characterized,0-9-19-25-46-49-90,49-51-58-61-67-81-87-90-107,a subset of LUPUS ERYTHEMATOSUS which is characterized unique,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805300,7/13/2014 11:36:16,,1321840682,7/13/2014 11:36:01,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,0-9-19-25,61-67,LUPUS ERYTHEMATOSUS,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805300,7/13/2014 11:41:53,,1321842880,7/13/2014 11:41:28,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,0-9-19-25,61-67,LUPUS ERYTHEMATOSUS,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805300,7/13/2014 11:43:11,,1321843511,7/13/2014 11:43:03,clixsense,1.0,24763049,GBR,"","",86.133.47.213,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS is a,0-9-19-25-46-49,49-51-58-61-67-81-87-90,a subset of LUPUS ERYTHEMATOSUS which is characterized,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805300,7/13/2014 11:50:20,,1321846045,7/13/2014 11:49:59,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,0-9-19-25,61-67,LUPUS ERYTHEMATOSUS,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805300,7/13/2014 11:51:47,,1321846594,7/13/2014 11:51:43,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS is a,0-9-19-25-46-49,49-51-58-61-67-81-87-90,a subset of LUPUS ERYTHEMATOSUS which is characterized,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805300,7/13/2014 11:55:41,,1321848096,7/13/2014 11:55:14,prodege,1.0,28022571,GBR,P2,Warrington,82.24.80.237,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS lupus erythematosus,0-9-19-25-61-67,0-9-19-25-61-67,Subacute cutaneous lupus erythematosus LUPUS ERYTHEMATOSUS,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805300,7/13/2014 12:00:48,,1321850150,7/13/2014 12:00:33,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,0-9-19-25,61-67,LUPUS ERYTHEMATOSUS,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805300,7/13/2014 12:02:50,,1321850931,7/13/2014 12:02:23,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,0,61,,,38,80,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,0-9-19-25,61-67,LUPUS ERYTHEMATOSUS,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities.,0 9 19 25,61 67,0,61,38,80,-1,RO-cause_of,900009,Subacute cutaneous lupus erythematosus (SCLE) is a subset of lupus erythematosus which is characterized by unique cutaneous manifestations and immunological abnormalities,Subacute cutaneous lupus erythematosus,lupus erythematosus
502805301,7/13/2014 11:27:27,,1321837202,7/13/2014 11:27:20,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,102,138,,,106,147,PAIN,NEURALGIA,but although the PAIN has features consistent with,85-89-98-102-107-111-120-131,120-131-136-138-149-153-159-111,"features consistent with a NEURALGIA, its cause is","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805301,7/13/2014 11:35:22,,1321840364,7/13/2014 11:35:18,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,102,138,,,106,147,PAIN,NEURALGIA,but although the PAIN has features consistent,85-89-98-102-107-111-120,120-131-136-138-149-153-159,"consistent with a NEURALGIA, its cause is","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805301,7/13/2014 11:45:42,,1321844487,7/13/2014 11:45:09,clixsense,1.0,27969116,NLD,04,Veendam,185.12.216.74,102,138,,,106,147,PAIN,NEURALGIA,PAIN,102,138,"NEURALGIA,","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805301,7/13/2014 11:47:05,,1321844926,7/13/2014 11:46:48,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,102,138,,,106,147,PAIN,NEURALGIA,PAIN,102,138,"NEURALGIA,","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805301,7/13/2014 11:50:56,,1321846298,7/13/2014 11:50:37,vivatic,1.0,25451531,GBR,"","",83.67.28.193,102,138,,,106,147,PAIN,NEURALGIA,PAIN,102,138,"NEURALGIA,","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805301,7/13/2014 12:03:15,,1321851056,7/13/2014 12:02:36,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,102,138,,,106,147,PAIN,NEURALGIA,PAIN,102,138,"NEURALGIA,","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805301,7/13/2014 12:03:35,,1321851186,7/13/2014 12:03:19,instagc,1.0,13763729,USA,"","",75.182.89.225,102,138,,,106,147,PAIN,NEURALGIA,PAIN,102,138,"NEURALGIA,","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805301,7/13/2014 12:03:46,,1321851223,7/13/2014 12:03:35,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,102,138,,,106,147,PAIN,NEURALGIA,PAIN,102,138,"NEURALGIA,","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805301,7/13/2014 12:07:32,,1321852529,7/13/2014 12:07:14,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,102,138,,,106,147,PAIN,NEURALGIA,PAIN,102,138,"NEURALGIA,","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805301,7/13/2014 12:13:32,,1321854472,7/13/2014 12:13:19,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,102,138,,,106,147,PAIN,NEURALGIA,PAIN,102,138,"NEURALGIA,","There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown.",102,138,102,138,106,147,-1,RO-has_definitional_manifestation,904803,"There is a high incidence of sciatica and of damage to the pelvic floor musculature, but although the pain has features consistent with a neuralgia, its cause is unknown",pain,neuralgia
502805302,7/13/2014 11:41:31,,1321842730,7/13/2014 11:41:12,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,ATOPIC DERMATITIS,201-208,141-129,"respiratory ATOPY,","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805302,7/13/2014 11:43:25,,1321843571,7/13/2014 11:43:06,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,ATOPIC DERMATITIS,201-208,129-141,"respiratory ATOPY,","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805302,7/13/2014 11:52:01,,1321846733,7/13/2014 11:51:49,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,ATOPIC DERMATITIS,201-208,141,"ATOPY,","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805302,7/13/2014 11:52:19,,1321846892,7/13/2014 11:52:17,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,those patients with ATOPIC DERMATITIS who had neither,181-187-196-201-208-219-223-227,118-126-129-141-148-152-156,"history of respiratory ATOPY, but was absent","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805302,7/13/2014 11:56:06,,1321848325,7/13/2014 11:55:56,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,ATOPIC DERMATITIS,201-208,129-141,"respiratory ATOPY,","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805302,7/13/2014 11:59:02,,1321849411,7/13/2014 11:58:44,vivatic,1.0,25451531,GBR,"","",83.67.28.193,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,ATOPIC DERMATITIS,201-208,129-141,"respiratory ATOPY,","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805302,7/13/2014 12:02:13,,1321850738,7/13/2014 12:01:52,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,ATOPIC DERMATITIS,201-208,129-141,"respiratory ATOPY,","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805302,7/13/2014 12:03:07,,1321850998,7/13/2014 12:02:44,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,ATOPIC DERMATITIS,201-208,129-141,"respiratory ATOPY,","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805302,7/13/2014 12:08:48,,1321852891,7/13/2014 12:08:31,neodev,1.0,18517457,GBR,"","",86.29.147.112,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,ATOPIC DERMATITIS,201-208,129-141,"respiratory ATOPY,","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805302,7/13/2014 12:12:58,,1321854211,7/13/2014 12:12:23,clixsense,1.0,8769423,AUS,06,Launceston,121.223.145.102,201,141,,,218,146,ATOPIC DERMATITIS,ATOPY,ATOPIC DERMATITIS,201-208,129-141-156,"respiratory ATOPY, absent","A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy.",201 208,141,201,141,218,146,-1,RO-cause_of,900443,"A strong MBP deposition was often seen in specimens from patients with atopic dermatitis who had a personal or family history of respiratory atopy, but was absent in specimens from those patients with atopic dermatitis who had neither a personal nor a family history of respiratory atopy",atopic dermatitis,atopy
502805303,7/13/2014 11:32:01,,1321838940,7/13/2014 11:31:51,clixsense,1.0,24763049,GBR,"","",86.133.47.213,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,(contact irritant and ALLERGIC DERMATITIS) and the common,100-109-118-122-131-143-147-151,34-46-57-71-78-85-90,"distinguish endogenous (dyshidrosis, ATOPY) causes from exogenous","The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805303,7/13/2014 11:40:23,,1321842240,7/13/2014 11:39:55,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,ALLERGIC DERMATITIS),122-131,71,ATOPY),"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805303,7/13/2014 11:42:29,,1321843208,7/13/2014 11:41:48,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,ALLERGIC DERMATITIS),122-131,71,ATOPY),"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805303,7/13/2014 11:42:46,,1321843347,7/13/2014 11:42:08,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,exogenous (contact irritant and ALLERGIC DERMATITIS),90-100-109-118-122-131,46-57-71-78-85-90-100-109-118-122-131,"endogenous (dyshidrosis, ATOPY) causes from exogenous (contact irritant and allergic dermatitis)","The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805303,7/13/2014 11:53:33,,1321847316,7/13/2014 11:53:15,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,ALLERGIC DERMATITIS),122-131,71,ATOPY),"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805303,7/13/2014 11:57:01,,1321848658,7/13/2014 11:55:22,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,ALLERGIC DERMATITIS),122-131,57-71-46,"endogenous (dyshidrosis, ATOPY)","The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805303,7/13/2014 11:57:06,,1321848674,7/13/2014 11:56:53,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,ALLERGIC DERMATITIS),122-131,57-71,"(dyshidrosis, ATOPY)","The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805303,7/13/2014 12:01:01,,1321850265,7/13/2014 11:59:01,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,(contact irritant and ALLERGIC DERMATITIS),100-109-122-131-118,57-71-46,"endogenous (dyshidrosis, ATOPY)","The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805303,7/13/2014 12:04:26,,1321851397,7/13/2014 12:04:08,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,ALLERGIC DERMATITIS),122-131,71,ATOPY),"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805303,7/13/2014 12:04:48,,1321851542,7/13/2014 12:04:25,neodev,1.0,18517457,GBR,"","",86.29.147.112,122,71,,,141,76,ALLERGIC DERMATITIS,ATOPY,ALLERGIC DERMATITIS),122-131,71,ATOPY),"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections.",122 131,71,122,71,141,76,-1,RO-cause_of,900276,"The pattern of eczema can help to distinguish endogenous (dyshidrosis, atopy) causes from exogenous (contact irritant and allergic dermatitis) and the common differential diagnoses (psoriasis, fungus infections",allergic dermatitis,atopy
502805304,7/13/2014 11:28:08,,1321837460,7/13/2014 11:27:51,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,? Medication overuse HEADACHE usually develops insidiously and,0-2-13-21-30-38-47-59,73-77-86-89-97-102-111-114-122-69,has the features of TENSION TYPE HEADACHE or chronic tension,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805304,7/13/2014 11:35:42,,1321840479,7/13/2014 11:35:25,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,HEADACHE,21,89-97-102,TENSION TYPE HEADACHE,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805304,7/13/2014 11:45:14,,1321844286,7/13/2014 11:44:57,gifthulk,1.0,22552178,AUS,05,Adelaide,121.45.89.85,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,HEADACHE,21,89-97-102,TENSION TYPE HEADACHE,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805304,7/13/2014 11:48:21,,1321845400,7/13/2014 11:47:22,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,HEADACHE,21,89-97-102,TENSION TYPE HEADACHE,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805304,7/13/2014 11:52:09,,1321846792,7/13/2014 11:52:05,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,? Medication overuse HEADACHE usually develops insidiously,0-2-13-21-30-38-47,73-77-86-89-97-102-111-114-122,the features of TENSION TYPE HEADACHE or chronic tension,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805304,7/13/2014 12:01:16,,1321850319,7/13/2014 12:00:59,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,Medication overuse HEADACHE,2-21-13,89-97-102,TENSION TYPE HEADACHE,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805304,7/13/2014 12:01:33,,1321850463,7/13/2014 12:01:16,neodev,1.0,18755947,GBR,H2,Accrington,80.47.185.52,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,? Medication overuse HEADACHE,0-2-13-21,89-97-102,TENSION TYPE HEADACHE,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805304,7/13/2014 12:05:22,,1321851720,7/13/2014 12:05:06,neodev,1.0,28269997,GBR,H9,London,151.224.171.48,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,? HEADACHE,0-21,89-97-102-111-114-122,TENSION TYPE HEADACHE or chronic tension,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805304,7/13/2014 12:09:42,,1321853268,7/13/2014 12:09:28,instagc,1.0,13763729,USA,"","",75.182.89.225,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,HEADACHE,21,89-97-102,TENSION TYPE HEADACHE,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805304,7/13/2014 12:13:54,,1321854624,7/13/2014 12:12:56,gifthulk,1.0,25566511,USA,"","",24.164.11.173,21,89,,,29,110,HEADACHE,TENSION-TYPE HEADACHE,Medication overuse HEADACHE,2-13-21,89-97-102,TENSION TYPE HEADACHE,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache.,21,89 97 102,21,89,29,110,-1,RO-has_definitional_manifestation,904986,? Medication overuse headache usually develops insidiously and often has the features of tension-type headache or chronic tension-type headache,headache,tension-type headache
502805305,7/13/2014 11:26:46,,1321836990,7/13/2014 11:26:40,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,maintenance associated with these TACHYCARDIAS.,154-165-170-176-79,75-79-91-94-111-123-127-137-65,induction and maintenance of SUPRAVENTRICULAR TACHYCARDIA and discusses the,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
502805305,7/13/2014 11:39:33,,1321841886,7/13/2014 11:39:16,eup_slw,1.0,21338859,GBR,K6,Portsmouth,86.6.113.168,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS.,176,79-91-94-111,maintenance of SUPRAVENTRICULAR TACHYCARDIA,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
502805305,7/13/2014 11:43:55,,1321843771,7/13/2014 11:43:44,clixsense,1.0,24763049,GBR,"","",86.133.47.213,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,associated with these TACHYCARDIAS.,154-165-170-176,75-79-91-94-111-123-127-137,and maintenance of SUPRAVENTRICULAR TACHYCARDIA and discusses the,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
502805305,7/13/2014 11:50:36,,1321846141,7/13/2014 11:50:11,vivatic,1.0,25451531,GBR,"","",83.67.28.193,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS.,176,94-111,SUPRAVENTRICULAR TACHYCARDIA,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
502805305,7/13/2014 11:51:32,,1321846524,7/13/2014 11:51:28,prodege,1.0,12944140,GBR,I4,Mitcham,92.21.66.102,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,associated with these TACHYCARDIAS.,154-165-170-176,75-79-91-94-111-123-127-137,and maintenance of SUPRAVENTRICULAR TACHYCARDIA and discusses the,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
502805305,7/13/2014 11:56:52,,1321848614,7/13/2014 11:56:39,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS.,176,94-111,SUPRAVENTRICULAR TACHYCARDIA,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
502805305,7/13/2014 12:01:10,,1321850312,7/13/2014 12:00:49,prodege,1.0,22360212,GBR,I1,Luton,82.6.41.191,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS.,176,94-111,SUPRAVENTRICULAR TACHYCARDIA,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
502805305,7/13/2014 12:01:42,,1321850500,7/13/2014 12:01:22,prodege,1.0,27934334,GBR,E4,Loughton,86.162.38.12,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS.,176,94-111,SUPRAVENTRICULAR TACHYCARDIA,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
502805305,7/13/2014 12:03:38,,1321851200,7/13/2014 12:03:27,neodev,1.0,18755947,GBR,H2,Accrington,80.47.185.52,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS.,176,94-111,SUPRAVENTRICULAR TACHYCARDIA,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
502805305,7/13/2014 12:03:46,,1321851219,7/13/2014 12:03:18,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,176,94,,,188,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS.,176,94-111,SUPRAVENTRICULAR TACHYCARDIA,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias.,176,94 111,176,94,188,122,-1,RO-has_definitional_manifestation,904614,This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias,tachycardias,supraventricular tachycardia
